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INTRODUCTION  
INTRODUCTION 
 
Preterm birth is truly a global problem. Countries with highest 
numbers include Brazil, India, Nigeria and the United States of America. 
1
 In 
the poorest countries on an average,   12% of babies are born too soon 
compared with 9% in higher income countries. 
2
 Preterm infants due to their 
immaturity of various organ systems are more likely to be admitted to the 
neonatal intensive care units (NICU) than their term counterparts who are 
likely to be by their mother side. During the process of birth, transport to 
NICU and various procedures of treatment and care, infant’s skin gets 
colonized by flora derived from the body of the mother, other human 
contacts and various inanimate objects.
3 
 The mechanisms leading to colonization of the skin involve a 
complex interplay among  rapid growth of commensal organisms, the 
development of the acid mantle,  local micro environmental factors such as 
occlusion and humidity and the choice of exogenous soaps and skin care 
practices.
4
 Initial colonization depends on the initial organism that colonize 
at a particular site as well as factors such as type of delivery, the amount of 
vernix present at birth, the type of nourishment received and the degree of 
exposure in the hospital environment.
5
 Though microbial colonization begins 
immediately after birth, it is low initially and the rate increases after 12 
hours. 
3 
 Most common organisms to colonize among the flora are 
staphylococcus, streptococcus, acinetobacter, klebsiella and candidal 
species
3
. Establishment of healthy skin microbiome may have a role in 
denying access to infectious microbiobes and help to modulate inflammatory 
responses. Coagulase negative staphylococcus a commensal bacteria plays a 
protective role by upregulating the expression of antimicrobial peptides such 
as human beta defensin-2 in a mature infant. 
6
  
 
In Preterm infants, at 28 weeks the stratum corneum consists of 2 or 3 
cell layers. By 32-34 wks there are more than 15 layers of corneocytes 
equivalent to that of adult skin.  Before 32-34 weeks, the thin stratum 
corneum does not effectively prevent against transepidermal water loss, 
percutaneous absorption of exogenously applied compounds or invasion of 
microorganisms. So even the normal flora may cause systemic infections in 
preterm infants because of the trans - cutaneous access through the immature 
skin barrier. 
6 
 
 During the first 2 weeks of life the epidermal barrier is immature and 
functionally compromised. Neonatal infections through the skin occur 
during this period.
7, 8
 Topical emollients like sunflower seed oil when 
applied topically augment skin barrier function and reduces the systemic 
infections in preterm    neonates.
9,10
 Topical application of antiseptics until 
the skin matures could prevent skin colonization and thereby reduce the 
systemic infections in neonates. 
 
Chlorhexidine is a broad-spectrum antiseptic.  It is used frequently for 
umbilical cord care in neonates.
11
 It is now being evaluated for topical 
application to the skin.  
 
In the studies undertaken in the community, a single skin cleansing 
with 0.25% chlorhexidine resulted in reduction in mortality among low birth 
weight infants
12
.
 
Hospital-based studies have shown reductions in skin flora 
and a reduction in the incidence of sepsis after topical chlorhexidine 
application. These studies involved term neonates predominantly.
13. 
 
Chlorhexidine is well tolerated by term neonates when applied by 
various means of applications like vaginal washings, umbilical cord 
cleansing and whole body cleansing
14,15,16
. Preterm infants less than 34 
weeks of gestation, have immature skin with increased permeability. There is 
concern that the neurological system in preterms may be vulnerable to toxic 
insults. Preterm babies have metabolic limitations resulting in decreased 
drug clearance. These handicaps predispose them to a higher rate of adverse 
reactions from chlorhexidine.  
 
Yet this population of preterm infants especially <34 weeks with 
increased susceptibility to infection and immature protective skin barrier 
may benefit from the antiseptics effects of chlorhexidine.  
  
  
 
 
 
REVEIW OF LITERATURE 
 
 
 
 
 
 
 
 
REVIEW OF LITERATURE 
The mortality from neonatal sepsis in the very low birth weight (VLBW) 
and premature infant group has not changed much from 18-20% and 80% in the 
developed and developing world respectively for last three decades.  The 
mortality is highest among these neonates and they stand twenty times greater 
chance of developing infection (often multiple) between birth and first month of 
life.
17
 There is also a greater chance of neuro-developmental delay among the 
neonates surviving the infections.
18
 Thus sepsis seems to be the most important 
cause of mortality and morbidity in this group of infants today. The sepsis rates 
are higher in these neonates because of increased exposure to microorganisms 
predisposed by risk factors and due to their weak host defense mechanisms.
17
 
  Risk factors predisposing to skin colonization 
 Newborn skin is virtually sterile and subsequent colonisation of the skin 
depends on varying exposures. Generally colonisation occurs within 2 - 7 
days.
19
 By virtue of certain risk factors the infants are confronted with 
microorganisms from maternal or external environment.
20, 21, 22 
Haque et al have  identified ‘risk factors’ that predispose VLBW infants to  skin 
colonization.
20
  
 
 
Maternal factors  
The maternal risk factors that predispose to early skin colonization are 
repeated vaginal examinations in labour, presence of chorio-amnionitis, 
prolonged rupture of membranes (> 18 hours) and maternal urinary tract 
infection during pregnancy. The colonisation on the infantile skin is similar to 
the maternal habitat. A retrospective epidemiological study of neonatal 
infections acquired through maternal contamination was carried out in a 
maternity unit by Blond et al. The infection rate was 0.61% in newborns and 
16% of the newborns, had asymptomatic colonisation  by bacteria.
23 
Among the 
various risk factors vaginal delivery and prolonged duration of premature 
rupture of membranes have significant positive correlation to neonatal 
colonization (p<0.02 and p=0.02, respectively) in the study by Ali GY et al.
24 
Dermal factors 
Acid mantle: The skin is alkaline at birth (pH of > 6). But in approximately 
four days an acid mantle develops (pH < 5). This acid mantle contributes for the 
protection against transcutaneous route of entry of microorganisms.
25
  
Vernix: Production of vernix begins by the end of 2nd trimester and most 
accumulate around 36-38 wks. The vernix caseosa helps to protect the fetal skin 
from damage from bacteria and amniotic fluid. It is composed of sloughed cells 
from the stratum corneum. It contributes to earlier skin acidification. In a study 
by Vissher et al in 2005, comparing term babies with retained vernix versus 
vernix devoid preterm infants at birth (p H– 5.16 vs. 5.97)  and 24 hours (pH 
4.9 vs. 5.63) at 24 hours  is lower for vernix retained infants.
26 
It is a natural 
skin cleanser and moisturiser.  Vernix contains LL-37 and  lysozymes  that 
exhibit anti bacterial effects against pathogens  such as E. Coli.
26 
 WHO 
guidelines recommends  not to remove the vernix from newborn skin because 
of these  anti- oxidant, anti- infective and wound healing  properties.
27 
 
Post natal events  
Though microbial colonization begins immediately after birth, it is slow 
at onset and the rate increases after 12 hours.
3
 This process is expedited if they 
either require resuscitation at birth and or are admitted to neonatal units.  
Other risk factors include low birth weight (1500 grams), GA less than 31 
weeks,  poor hand washing practices, umbilical catheterization, total parenteral 
nutrition (TPN), prolonged or un-necessary use of antibiotics and  long line 
insertion.
19
  After birth,  risk factors with highest significance were  low birth 
weight, prematurity and use of invasive techniques  (p < 0.04, p = 0.03 and 
p = 0.03 respectively). 24  
The use of central venous catheters, mechanical ventilation, parenteral 
nutrition, and exposure to other invasive skin- or mucosa-breaching procedures 
in the nurseries increase the risk of CoNS infection substantially described by 
Dimitriou, G, et al. In that study, intubation and presence of central indwelling 
catheters were important risk factors for persistent CoNS infection when 
assessed separately; however, the biofilm production was the only significant 
effect when the risk factors were tested jointly (OR 4.69; 95% CI 1.59-13.84).
28 
  
Weak defense mechanisms in Preterm neonates 
The host defense mechanisms that are present in the newborns are 
 Physical barriers – keratinised skin , mucus membranes enzymes and 
secretory IgA , etc. 
 Passive immunity acquired through placenta 
 Active immunity –both innate and adaptive or specific immunity.17 
Skin – A weak barrier in Preterm infants 
 Maturation of the epidermal layers includes keratinisation, which results 
in the differentiation of granular and stratum corneal layers and the formation of 
a water-impermeable barrier. The stratum corneum of a preterm baby is thinner 
and immature than that of a term baby. Mature stratum corneum is made up of 
10-20 layers of cells (a thickness of 2 mm) and the stratum corneum of preterm 
babies <30 weeks may only have 2-3 layers (0.9 mm thick).Thickness of the 
stratum  corneum plays an important role in its barrier function. An intact 
mature stratum corneum helps to protect the skin from surface 
microorganisms.
30
 (Fig.1) 
 
 
 
  
 
 
 
FIGURE : 1 
 Preterm skin at 26-27 weeks                      Term infant skin  
 The stratum corneum begins to develop at approximately 24 weeks of 
gestation. The epidermis matures only around 32- 34 weeks of gestation. Before 
32-34 weeks, the thin stratum corneum does not effectively prevent against   
invasion of microorganisms.
5
  
 The skin secretes Adenylate Mono Phosphate, which are early-response 
factors creating a microbicidal shield particularly effective against CoNS. In 
preterm neonates, the immature stratum corneum fully matures to secrete these 
factors only at one to two weeks after birth.
31
  
           Kalia et al studied the acid mantle in the preterm infants and stated that 
the acid mantle may not develop in preterm babies at the same rate as term 
neonates. In Premature infants pH is 5.5 after one week, 5.1 after one month, 
and in diapered area pH is 6.0 and hence their skin may not be well protected 
from bacteria.
32 
 The vernix caseosa, a waxy coating on neonates’ skin mainly formed 
during the last trimester of pregnancy provides additional antimicrobial 
protection in mature neonates. Hence born too soon before 34 weeks deprives 
the preterm infants the mechanical barrier effect as well as the antimicrobial 
defense systems of  the vernix. 
          Preterm infants have immature immune systems. Qualitative and 
quantitative deficiency of complement and IgG factors in these infants and 
particularly in the VLBW population increases the risk of CoNS infection.        
So even the normal flora may cause systemic infections in preterm infants 
because of the transcutaneous access through the immature skin barrier.
6 
 Skin colonisation profile and transcutaneous sepsis 
Neonates are normally colonized within 12 hours to first few days after 
birth by both Gram-negative and Gram-positive organisms and Candida 
species. Most common organisms to colonise among the flora are 
staphylococcus, streptococcus, acinetobacter, klebsiella and Candida species.
3,33
 
Coagulase negative staphylococcus (CoNS) is a common inhabitant of the skin 
and mucous membranes as described by Hira et al. A small proportion of 
neonates acquire CoNS by vertical transmission, many acquire primarily 
horizontally. S. epidermidis was the most prevalent species among skin (33%), 
S. warneri (23% vs. 9%, P=0.002). S. haemolyticus prevalence increased 
significantly over time among skin isolates (9%, T=24 hours vs. 25%, T=21 
days, P=0.002).
34
  
Several studies suggest that persistent CoNS infection is increasing in 
preterm infants in modern NICUs.
28, 35
 The rate of persistent CoNS infection 
ranges between 13% and 48%. CoNS is usually the causative pathogen in 40% 
to 77.6% of episodes of blood stream infection in neonates. The incidence is 
inversely related to gestational age and birth weight.
34 
           Chien et al. showed that 22.5% of infants admitted to NICU required 
CVCs  and the incidence of blood stream infection in this study varies from 2.9 
per 1000 non catheter days, to 7.2 per 1000 umbilical venous catheter days and 
13.1 per 1000 percutaneous catheter days.
36
  
Protection against transcutaneous route 
The options available for disinfecting the neonatal skin are povidone 
iodine, chlorhexidine and isopropyl alcohol.  
Alcohol are rapidly bactericidal at 60-90% concentration rather than 
baceteriostatic. Alcohol causes skin burns in preterm neonates. They also 
evaporate rapidly, making extended exposure time difficult to achieve. FDA has 
not cleared any liquid chemical sterilant or high level disinfectant with alcohol 
as the main active ingredient. 
45
 
           Antimicrobial properties of iodine were first demonstrated in 1882 by 
Davaine. Povidone iodine has extensive evidence to support its use as skin 
disinfection before surgery and procedure. But its use is controversial in preterm 
newborns due to perceived issues with toxicity and systemic absorption. 
Chlorhexidine – a better option  
In the study by Mimoz et al, the incidence of blood culture contamination 
was reduced more by chlorhexidine than povidone-iodine (14 of 1019 cultures 
[1.4%] compared with 34 of 1022 cultures [3.3%]; odds ratio, 0.40 [95% CI, 
0.21 to 0.75]; P = 0.004).
37 
A comprehensive review of current evidence in the Cochrane database 
found some evidence that skin preparation with 0.5% chlorhexidine in 
methylated spirits preoperatively was associated with lower rates of superficial 
skin infections following clean surgery than alcohol-based povidone iodine 
paint.
38
 
            Linder et al described in two studies the effect of topical iodine-
containing antiseptics in the preterm neonates on their thyroid function tests. 
The mean thyrotropin levels were elevated in preterm babies exposed to iodine  
(15.4 vs 7.8 mIU/L, p < 0.01). Among the iodine-exposed infants, elevated 
thyrotropin levels (> 30 mIU/L) were found in 13.7% of infants, compared with 
none in the chlorhexidine-treated group (p < 0.01). T4 and thyrotropin levels 
were measured weekly during the first 28 days, one every 2 weeks until the age 
of 60 days, and at the age of 90 days. Among iodine-exposed infants, 20.8% had 
thyrotropin values > 30 mIU/L, whereas none of the infants in the chlorhexidine 
group had elevated thyrotropin values (p < 0.05). Elevated urine iodine levels 
were present reflecting abnormally high iodine absorption. 
39
 
 
Chlorhexidine  
Mechanism of action  
 
 Chlorhexidine gluconate is used as a topical broad spectrum antiseptic. It 
is said to control antibiotic resistant bacteria and prevent infections. 
Chlorhexidine gluconate is used in concentrations ranging from 0.5% - 4% for 
topical antiseptic effect with or without alcohol.  
 
FIGURE 2 : MECHANISM OF ACTION OF CHLORHEXIDINE 
 In low concentrations it affects membrane integrity and high 
concentrations acts through cytoplasm causing cell death. Chlorhexidine is a 
positively-charged molecule. It binds to the negatively-charged sites on the cell 
wall and destabilizes the cell wall to interfere with osmosis. The bacterial 
uptake of the chlorhexidine is within 20 second.  
 The integrity of the cell wall is affected when applied in low 
concentrations. Once the cell wall is damaged, chlorhexidine then crosses into 
the cell itself and attacks the cytoplasmic membrane (inner membrane). Damage 
to the cytoplasm's delicate semipermeable membrane allows for leakage of 
components leading to cell death. Chlorhexidine causes the cytoplasm to 
congeal or solidify in high concentrations.(Figure 2)
 
 
 
In topical applications, chlorhexidine has the unique ability to bind to the 
proteins present in human tissues such as skin and mucous membranes with 
limited systemic or bodily absorption.  Chlorhexidine that is protein bound is 
released slowly leading to prolonged activity. This phenomenon is known as 
substantivity. This allows for a longer duration of antimicrobial action against a 
broad spectrum of bacteria and fungi.The antimicrobial activity of chlorhexidine 
has been documented to last 48 hours on the skin.
40 
Chlorhexidine is used for 
the following purposes in the NICUs in United states
41
.(Figure 3). 
 
FIGURE 3 : USAGE OF CHLORHEXIDINE IN THE NICUs  
 
 
Preparations 
It is commercially available as  
 2 % CHG in 70%   isopropyl alcohol  
 0.5 % CHG in 70 % isopropyl alcohol 
 2 % CHG aqueous 
 Literature from adult studies has shown that both 2% chlorhexidine in 
70% alcohol and as 2% aqueous chlorhexidine can provide effective skin 
antisepsis though alcohol containing solution had more long lasting effect
42
. It is 
also well known from many case reports that alcohol containing products when 
used to clean abdominal skin for neonatal procedures can cause severe skin 
damage in preterm infants
43
. As a result many neonatal units have adopted 
aqueous chlorhexidine as antiseptic agents.
43 
Trials are planned
 
and ongoing to 
compare the efficacy and safety of chlorhexidine in alcoholic and aqueous 
preparations.
44
  
 Chlorhexidine is combined with alcohol for certain advantages. Alcohol 
has very rapid onset of action (10 seconds). When Chlorhexidine gluconate is in 
combination with alcohol the microbicidal action starts immediately on 
application to the surface. Moreover alcohol has got a good bactericidal action 
against gram negative organisms compared to chlorhexidine which has a high 
level of resistance to non fermenting gram negative organisms.
45
  
 
 
Adverse skin reactions
 
 Chlorhexidine is used in the NICUs in US and a survey was conducted by 
Tammana et al on its usage. Fifty percent of the NICUs using chlorhexidine 
reported adverse skin reactions in that study but no NICU reported systemic 
toxicities. Skin burns was the most common reaction and  erythema being 
second most common. These centers, which reported  side effects noted that the 
burns occurred in neonates with birth weights <1500 g.
41
 Chlorhexidine with 
alcohol have been reported to cause burns in infants between 24 and 26 weeks 
gestational age compared to aqueous preparations.
46
 
Systemic absorption 
 Another issue of interest would be absorption of chlorhexidine through 
the immature skin of preterm infants. In spite of its recommendations for skin 
preparations before procedures, the Centre for Disease Control and Prevention 
is apprehensive about recommending chlorhexidine for infants less than 2 
months of age
45
. Much apprehension about chlorhexidine usage in NICUs is 
caused by the aftermaths created by its predecessor Hexachlorophene. 
           Hexachlorophene required multiple applications for its maximal    
antibacterial effects. But multiple applications more than 3 times produced 
irreversible brain damage in preterm causing vacuolar encephalopathy.
47
 
 Serum levels of Chlorhexidine may correlate with the strength of the 
topical chlorhexidine solution used, as neonates exposed to 1% CHX had 
significantly higher blood concentrations of chlorhexidine compared with 
neonates exposed to 0.25% and 0.5% concentration solutions. Theoretically 
sites like face, scalp may have increased vascularity contributing to increased 
blood levels when applied topically. However no site-specific safety data 
exists
48
. Alcohol potentiates absorption of chlorhexidine when applied 
topically.
49
 In general, the potential for absorption appears to be reduced when 
chlorhexidine is applied in aqueous or other non ethanol-based formulations
50
.  
Studies with chlorhexidine  in neonates 
Skin colonisation  
 The effect of   first   bath   with   chlorhexidine was studied by L.Da 
Cunha et al  in a randomized   masked trial in 2008 to reduce the staphylococcal 
colonization on newborn skin. The trial was conducted in ninety three neonates 
who received the first bath with chlorhexidine (n =44) or neutral liquid soap (n 
=49). Staphylococcus aureus colonization prevalence was 10.2% in control and 
4.5% in the experimental group (p =0.74). Thirty minutes after bath, S. Aureus 
prevalence was 20.4% in control and 2.3% in the experimental group (p 
=0.017). Twenty four hours after bath, S.Aureus prevalence was 36.7% in 
control and 13.6% in the experimental group (p =0.021). There was no 
occurrence of sepsis in the first month in both groups. In conclusion, a first bath 
with chlorhexidine reduced S.Aureus colonization on the newborn’s skin in a 
24-h period.
51
 
 In a randomised controlled trial by Gary L Darmstedt et al in 2007, the 
skin of the hospitalized out born newborns admitted to a hospital, in Bangladesh 
was cleansed within 72 hours  with baby wipes containing 0.25% chlorhexidine 
(n = 67) or placebo (n =66) solution. Skin swabs were taken from axillary, peri-
umbilical and inguinal sites at baseline and 2 hours, 24 hours, 3 days and 7 days 
after treatment. Skin colonization rates were analysed both qualitatively and 
quantitatively.  
 Percent of positive cultures at baseline varied by site: 74.4%, 39.1%, and 
61.7% from the axillary, periumbilical, and inguinal sites, respectively. Skin 
colonisation rates at two hours after cleansing were approximately 35%–55% 
lower than the baseline rates for both groups at all three sites. For the 
chlorhexidine group, positive skin culture rates remained significantly lower 
than the baseline rates for 24 hours to three days, whereas for the placebo group, 
beyond the first 2-hour follow-up, these values were not lower than baseline in 
all 3 sites.  
 Chlorhexidine skin treatment produced more extended skin cleansing 
effects than placebo. The skin condition was not different between the groups. 
The reduction in the temperatures was also not significant. It was concluded that 
the possible quantitative and qualitative reductions observed in the skin flora 
might contribute to reducing neonatal infections.
52
 
           In another randomized trial done by Luke C Mullany et al in 2008   
among the hospital born newborns were randomly allocated to full-body skin 
cleansing with 0.25%, 0.5%, or 1.00% concentrations of  chlorhexidine 
solution. Skin swabs were collected from the three sites - axilla, inguinal and 
peri-umbilical areas at baseline at 2hours and 24hours after treatment. The 
overall proportion of positive swabs at baseline was 60%. There was a dose-
response trend for each of the separate sites. In all three study arms, the positive 
skin culture rate was significantly lower at each of the three sites sampled 2 
hours after the intervention. The reduction in colonization was greatest among 
the 1.00% group (63% reduction), followed by 0.50% group (50% reduction) 
and 0.25% group (48% reduction)
48
. 
 At 24 hours, positive skin culture rates returned to baseline levels for all 
three sites in the 0.25% group. In the 0.50% group, only swabs from the axilla 
tended to still be lower than observed prior to the intervention, while in the 
1.00% group, the positive rate remained lower than baseline at all three sites, 
and significantly lower among axillary and peri-umbilical swabs. Effect at 24 
hours was highest in the 1.00% CHX group (37% lower positive skin culture 
rate); but did not achieve statistical significance.
48
 
 In view of preterm population (<34 weeks) being less in number in the 
previous studies, MJ Sankar et al  (2009)  AIIMS  randomised 28- 34 week 
infants within 3 hrs of birth into the following three groups: 0.25% 
chlorhexidine, normal saline or no skin cleansing. Skin condition, axillary 
temperature and skin colonization rates in the axilla and the groin were assessed 
at specified time intervals after intervention. Rate of culture positivity in the 
swabs taken at 24 hours were 22.2, 52.7 and 57.9% in the chlorhexidine, saline 
and no cleansing groups, respectively (P=0.06).  
   
 In the axillary region chlorhexidine reduced the risk of colonization by 
sixty two percent compared with no cleansing (RR: 0.38; 95% CI: 0.15, 0.98). 
However, no such reduction was observed when compared with saline (RR: 
0.42; 95% CI: 0.16, 1.10). At 72 hours, the colonization was not different 
between the groups. In the groin no reduction in colonisation was observed 
either at 24hrs or 72 hrs after the cleansing. There was only a minimal reduction 
(mean 0.5°C) in body temperature and no adverse effects on skin condition 
were observed.
53
 
Mortality 
 The study conducted in Nepal, a community based trial by Teischl et al in 
2007, cleansed newborn infants  with infant wipes that contained 0.25% 
chlorhexidine soon after birth (median: 5.8 hours) and found reduction in 
neonatal mortality only among low birth weight infants.
12
 
 There were 4 more studies – 3RCTs 12,14,54 and 1before and after study13 
reporting on mortality after chlorhexidine intervention combining both vaginal 
washing and neonatal cleansing. After a pooled analysis in a systematic review 
there was no difference in mortality between the chlorhexidine and the control 
groups.
55
 
Reduction of sepsis 
 Da Cunha et al 2008, reported on decrease in staph colonisation rates in 
the neonates after chlorhexidine cleansing at birth. None of the neonates 
developed sepsis.
51 
The systematic review found no reduction in the incidence 
of sepsis.(RR0.97; 95% CI 0.80 – 1.18).55  
Hypothermia  
 Three studies (Pereira et al, Darmstadt et al, Sankar et al)  reported   
hypothermia.
16,52,53 
Two studies
 
reported greater incidence of hypothermia in the 
chlorhexidine group in the first 30 minutes after the intervention.
 52 
 Majority of 
neonates had only mild hypothermia (36.0 to 36.4
0
C). But the  study
   
 by  Cunha  
et al showed no difference with chlorhexidine and neutral soap.  
Skin reactions 
 Garland et al  reported severe contact dermatitis with the use of a CHG-
impregnated dressing that was placed over catheter sites after insertion
56
. In 
these episodes of contact dermatitis secondary to CHX, it seems that the 
occlusive adhesive dressing causes external pressure restricting capillary 
perfusion to the skin and causing local skin breakdown.  
 There are no reports of contact dermatitis in neonates who received full-
body skin cleansing with chlorhexidine, even in very low birth weight  neonates 
and as young as 28 weeks gestational age. The trial at Zimbabwe in 2011 by 
L.Pereira et al 
16
 has concluded that 1% CHX was safe in neonates. Two 
trials
51,53
 did not report any skin rash in both the control or the intervention 
group.  
Systemic absorption of chlorhexidine 
 
 From the previous studies by Mullany et al, Aggett et al, Cowen et 
al
48,49,50 
comparing the blood concentrations of chlorhexidine  was difficult 
because the samples were collected differently (heel stick versus venipuncture) 
and different laboratory assays were used for measurement. A standard method 
to detect CHX in the blood does not seem to exist. After cleansing with 
chlorhexidine,the percutaneous absorption that occurs, particularly in preterm 
neonates is only minimal.  The strength of the chlorhexidine that is both 
effective and non-toxic when used topically is not known.   
Gaps in knowledge and rationale for the present study 
 Preterms with their weak defense mechanisms would definitely benefit 
from the antiseptic effects of whole body cleansing with chlorhexidine. But 
there is  paucity of evidence regarding the appropriate dose, dosing interval, 
clinical benefit and safety of chlorhexidine in this population. Previous trials 
with single application of 0.25% CHX were not producing consistent effects on 
reduction in skin flora.  The previous alcoholic preparation of chlorhexidine 
produced considerable skin toxicity. 
 There is a need for a clinical trial with higher concentrations of 
chlorhexidine  as multiple applications at intervals from birth to produce a 
consistent and sustained reduction effect on skin flora was felt.  
 The substantivity effect of chlorhexidine would extend only till 48 hours 
at the maximum. Hence multiple applications at this interval would be more 
appropriate. 
 But the safety of chlorhexidine when applied repeatedly on the immature 
preterm skin remains a concern in terms of skin toxicity, thermal stability and 
neurotoxicity.  
 The safety of aqueous form in the preterm skin without much increase in 
nosocomial colonisation and infection with gram negative organisms needs to 
be established. 
 
  
  
 
 
 
 
 
 
HYPOTHESIS AND 
OBJECTIVES 
  
HYPOTHESIS AND OBJECTIVES 
Hypothesis 
 Multiple whole body cleansings with 0.5% chlorhexidine in haemo 
dynamically stable neonates between 28 - 34 weeks of  Gestational Age and 
birth weight more than 1000 grams will reduce the skin colonisation on the skin 
surface during the first weeks life when compared to cleansing with sterile 
water. 
Objectives 
Primary Objective   
 To study the skin colonisation rates (swabs with culture positivity)   on 
the seventh day of life in the axillary region after multiple whole body 
cleansings with 0.5% chlorhexidine (intervention group) and sterile water 
(placebo group) were measured and compared. 
Secondary objectives: To compare the following in the infants after multiple 
whole body cleansings with either 0.5% chlorhexidine or sterile water.   
1. Mortality within first 28 days of life. 
2. Incidence of Sepsis within seven days of life 
3. Proportion of infants requiring repeat hospital admissions within 
 first 28 days of life. 
4. Skin colonisation rates (swabs with culture positivity) at baseline,   24 
hrs and 48 hrs after recruitment in the axilla and inguinal  regions. 
5. Mean bacterial colony counts in the culture positive swabs taken at 
 baseline, 24 hrs, and 48 hrs after recruitment and on day seven  of  life 
in both the axillary and inguinal regions. 
6. Mean skin temperatures at baseline, 5 and 15 mins after each 
 application.  
7. Skin condition by using the Newborn skin condition scoring scales. 
 (Annexure - 6) before each cleansing and on seventh day. 
8. Skin colonisation  profile 
 
 
 
 
 
 
 
 
 
  
  
 
 
 
 
 
 
MATERIALS AND 
METHODS 
MATERIALS AND METHODS 
Study design  
 Double blinded, Randomised controlled trial with a superiority frame 
work.  
Study centre  
 The study was conducted in the neonatal unit of the Institute of Obstetrics 
and Gynaecology, Madras Medical College, Chennai – a tertiary level Unit at 
Chennai.  
Study Period 
        The study was undertaken from November 2013 to February 2014. 
Subjects: Study population  
 Neonates between 28 -34 completed weeks of GA, admitted during the 
study period in the unit were assessed for eligibility with the following inclusion 
criteria 
Inclusion criteria 
 Hemo dynamically stable 
 Birth weight more than 1000 grams  
 No encephalopathy at the time of recruitment. 
 
 
The following neonates were excluded  
Exclusion Criteria 
 Major congenital malformations 
 Skin defects in epidermis involving more than 5% of body surface 
 area. 
Sample size 
 The sample size was determined from the pilot study undertaken in the 
unit as there were no studies documenting the effect of multiple applications of 
chlorhexidine on the skin colonisation.  
 The skin colonization rates in the Preterm infants on day 7 of life 
determined from the pilot study were 90% and 64.4% in the control and  
intervention group respectively. Thus to detect a difference of 25% between the 
intervention  and the control groups using a two sided Fisher’s Exact test with 
significance level of 0.05 and power of  90%  we calculated  a sample size  of  
60 infants in each group and enrolled 120 infants in the study .   
Methodology 
Assessment for eligibility 
 All Preterm infants between 28 – 34 weeks of completed gestation 
admitted during the study period within 6 hrs, weighing more than 1000 grams, 
haemodynamically stable and without encephalopathy were included in 
thestudy.   
Gestational age (GA)  
 Gestational age was calculated by first trimester ultrasound dating or 
from the first day of the last menstrual period based on availability. Infants were 
classified based on the Fentons intrauterine growth charts. Infants whose birth 
weight fell below  the10
th
 centile were considered as small for gestational and 
those weighing more than 90
th
 centile as large for gestational age. 
Hemodynamic stability was defined as follows: 
1. Infants maintaining O2 saturation of 88-92% without signs of 
 respiratory distress either in  
 Room air or  
 Fio2  requirement ≤ 50%, PEEP ≤ 7 cm of H2O on CPAP 
 MAP ≤ 8 cm, Fio2 ≤ 30% on mechanical ventilation 
2. Infants with normal perfusion status or requiring only one inotrope, 
 dose not more than 10mcg/kg/min to maintain a normal perfusion 
 status. 
           Infants with major congenital malformations and skin defects involving 
more than 5% of body surface area were excluded.  
Consent and Ethical clearance  
 Informed written consent for the trial was sought from the parents before 
enrolment (Appendix 3A,4A). Parents were explained in detail about the 
relevance of the study and about the benefits and possible adverse reactions. 
They were also provided with the participation information sheet which was 
printed in Tamil and English (Appendix 3B,4B). The trial was cleared by the 
Institutional Ethical Committee. (Annexure 1A - EC Reg No. 
ECR/270/Inst./TN/2013). 
Stratification  
 Neonates were stratified into two groups based on the gestational age; 
Stratum A (28-31 weeks) and stratum B (32-34  weeks). Within each stratum, 
infants were randomised to receive cleansing with either 0.5% chlorhexidine 
(intervention) or sterile water (placebo).  
Randomisation  
     Computer  generated  random  numbers with variable block sizes (4 to 6)    
were used to allocate the neonates into the intervention and the control groups.     
 Zipped packets containing 4 individually sealed wipes were numbered 
according to the computer generated random numbers. (Fig.5) Packets were 
opened in the serial order after recruitment of each patient and wipes from that 
packet were used for three cleansings performed at 0, 48 and 96 hours after  
recruitment. (Fig.6) Fourth wipe was placed in the packet for an eventuality of 
accidental tumbling. 
Blinding 
 The packets containing the wipes with either chlorhexidine or sterile 
water were prepared by the same manufacturer and they looked similar in all 
respects. Neither the care giver nor the principal investigator could make out 
any difference between the wipes 
  
 
 
 
 
FIGURE: 4. WIPES IN SEALED COVERS 
 
 
 
 
 
 
       FIGURE: 5. FOUR WIPES IN ZIPPED PACKETS 
 
 
 
 
 
 
 
 
 
FIGURE: 6. PACKETS ARRANGED IN SERIAL ORDER 
  
Procedure     
 After recruitment, the baseline characteristics were entered onto the data 
collection forms (Annexure 2). The skin condition of the infant was scored 
according to the Newborn skin condition scoring scales (Annexure 6) and the   
axillary temperature was recorded before cleansing, at 5min & 15 min after 
each cleansing procedure.  
Intervention  
 The neonates were cleansed with specially prepared body wipes sealed in 
covers and packed in zipped packets. Each contained four sealed wipes. Inside 
the sealed cover there was a single wipe which was divided into five portions by 
an impression line (Fig.4 & 8).  
 The duty staff/principal investigator wiped the infant skin (except face 
and scalp) from the neck till the soles in five steps. The body was divided into 
five parts and one portion of the wipe was used for each part of the body .The 
parts were; Neck and chest, Abdomen, Perineum, Upper limbs and Lower limbs 
(Fig.9). 
 To achieve consistency in the procedure of skin cleansing, the nurses in 
the nursery were trained using wipes on a mannequin. Instruction sheet was 
made available in the unit during the study period. 
 
  
  
 
 
 
 
FIGURE: 7. SKIN SMEAR TAKEN FROM AXILLA 
 
 
 
 
 
 
FIGURE: 8. CHLORHEXIDINE AND STERILE WATER WIPES 
 
 
 
 
 
 
 
 
FIGURE: 9. CLEANSING PROCEDURE 
Physician in charge took decision about the day to day management of the 
neonate. He / she were not a part of the study and were blinded to the 
intervention. Routine skin care was not provided during the period of study. The 
infants were followed up for development of adverse reactions on the skin and 
for sepsis. 
Skin smears  
 Skin smears were taken with sterile swabs from the right axilla and the 
right inguinal regions at baseline, 24 hrs and 48 hrs after recruitment and on the 
7
th
 day of life (Fig.7). Swabs were pre-soaked in distilled water. Swabs were 
rubbed five times both horizontally and  vertically rotating 360 degrees in the 
sampling area. The swabs were placed in transport medium (Trypticase soy 
broth) and sent to the micro lab immediately after collection (Fig.11 & 12). To 
ensure proper dispersion of the contents of the swab, they were vortexed  into 
the medium, then the inoculum (0.01 ml) was placed onto the sheep blood agar 
and Mac Conkey agar media by using a calibrated loop and then incubated at 37 
0
C for 18 to 24 h. 
 
 
 
 
 
 
 
  
 
 
 
 
 
FIGURE: 10. SWABS AFTER COLLECTION 
 
 
 
 
 
 
FIGURE: 11. SWABS TRANSPORTED IN TRYTICASE –  
SOY BROTH 
 
 
 
 
 
 
                         FIGURE: 12.SWABS VORTEXED IN MEDIUM 
Skin colonisation 
 Skin colonisation was measured by  
Qualitative analysis: culture positive swabs (growth of any organism) 
Gram staining was done as per the standard procedure. 
Quantitative analysis: bacterial colony counts from the swabs         showing 
positive growth.  
 Bacterial colony counts were determined by semi quantitative analysis 
(100 colonies in 0.01 ml inoculums would amount to 10
5
 colonies per milliliter). 
 
Sepsis work up 
 The infants were subjected to detailed sepsis work up on clinical 
suspicion of sepsis until 7 days of life. 
1. Sepsis was defined based on combination of clinical course,  indirect 
laboratory markers and bacterial culture results  
2. Sepsis defined as: 
 Culture positive: Infants with signs and symptoms suggestive of sepsis 
and blood culture positive. 
 Culture negative: Infants with signs and symptoms suggestive of sepsis, 
positive sepsis screen and blood culture negative. 
       3. Positive sepsis screen : ≥ 2 parameters positive 
Total leucocytes count <5000mm
3, ANC high or low as per mouzinho’s charts , 
micro ESR  (1 hour > age +3 mm in first 7 days of life) and qualitative CRP.  
Follow up    
 All infants were followed up until 28 days of life prospectively during the 
routine postnatal checkups and immunisation sessions and through telephonic 
contacts for readmissions and neonatal mortality. 
Data collection: All the data were entered in the data collection form.                 
(Annexure 2) 
 
Statistical analysis 
 Categorical variables are reported in proportions (odds ratio or relative 
risk with 95% C.I) Chi square was used for comparison. Continuous variables 
are reported with mean or median and standard deviations or inter quartile 
ranges. Student t test was used for comparison when the data had a normal 
distribution and non parametric tests like Mann Whitney U tests and Wilcoxon 
rank sum analysis were used for skewed distribution. A  P value < 0.05 was 
considered statistically significant. 
  
              
 
FIGURE 13 
TIME LINE OF EVENTS DURING THE STUDY 
DAY OF LIFE 
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BASELINE SKIN SMEAR TEMP @ 
BASELINE,
5,15MINS 
FIRST  CLEANSING  
SKIN SMEAR @ 24 HRS 
SKIN SMEAR @ 48 HRS TEMP @ 
BASELINE,
5,15MINS 
 
SECOND  CLEANSING  
TEMP @ 
BASELINE,
5,15MINS 
 
THIRD  CLEANSING  
SKIN SMEAR @ DAY 7 
SKIN SCORING 
Measurement of outcomes 
Table 3.1 Measurement of outcomes in the study 
Outcome Time Tools Sampling  Reporting 
Skin colonisation  
 Culture 
positive swabs 
 
 Colony 
counts  
 Baseline 
 24 hrs 
 48 hrs after         
1
st
 cleansing 
 Day 7 
 
Sterile swabs  
Trypticase        
soy broths 
Sheep blood agar  
Macconkey agar  
Principal 
investigator 
Microbiologist 
Skin temperatures   Baseline 
 5min 
 15min 
after each 
cleansing 
Temperature 
probe 
Digital 
thermometer 
 Principal 
investigator 
Skin condition   Baseline 
 before 
each cleansing  
 Day 7 
Newborn skin 
condition scoring 
scales 
 Principal 
investigator 
Sepsis workup  On clinical 
suspicion 
Total leucocytes 
count 
Absolute 
neutrophil count 
CRP 
µ- ESR 
Primary 
physician 
Microbiologist 
Pathologist 
Follow-up Day 28 of life PN visits 
Telephone 
contacts  
PN visits 
 Principal 
investigator 
 
  
  
 
 
 
 
 
RESULTS AND ANALYSIS 
RESULTS 
 
 During the study period 154 neonates between 28-34 weeks of gestational 
age were born in our Institute. Of these 137 were eligible for inclusion. Of them 
120 neonates were recruited for the study after obtaining parental consent. The 
included neonates were 28-34 weeks of gestational age neonates who were 
admitted into the unit, who weighed more than 1000 grams, and stable haemo 
dynamically without encephalopathy. 17 preterm infants were excluded for 
reasons like skin defects involving more than 5% of Body surface area(1), 
major congenital malformations(4), delay in recruitment (9) and non availability 
of the principle investigator (3).  
 120 preterm neonates who were enrolled were stratified into two strata. 
Stratum A (28-31 weeks gestation) had 31 neonates and stratum B (32-34 weeks 
gestation) had 89 neonates. The stratified neonates were randomised by the 
computer generated randomised sequence into either the intervention group 
(n=59) or the control group (n=61). The intervention group received whole body 
cleansing with wipes containing 0.5% chlorhexidine gluconate and the placebo 
group cleansing with wipes containing sterile water.The baseline neonatal and 
maternal characteristics were collected and tabulated.  
 All of the 59 neonates who were allocated to the chlorhexidine group, 59 
infants received the intervention within 6 hrs of birth. Since one infant died on 
the second day and was not available for intervention at 48 hours 58 infants 
were cleansed at 48 hours after recruitment. Subsequently 2 infants died and 
only 56 neonates received the third cleansing at 96 hours after recruitment. 
Similarly in the placebo group 61 infants received the first cleansing at 
recruitment, 60 infants at 48 hours and 57 infants at 96 hours after the 
recruitement. Totally the intervention and the control groups had four and five 
deaths respectively. The chlorhexidine group had 55 infants and the placebo 
group had 56 infants for analysis of the primary outcome on day 7 postnatal 
age. The infants were monitored until the end of first week of life for features of 
sepsis as per the unit protocol.  
 The infants were followed up after discharge until day 28 during their 
visits for routine post-natal checkups and immunisations or by contacting 
through telephones if they had not been brought for follow up. The details in 
case of mortality and repeat hospital admissions were sought. Two infants one 
in intervention and one in control group were lost to follow-up after discharge 
from the hospital (Fig 14). 
  
FIGURE 14. RANDOMISATION FLOW CHART 
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COMPARISON OF BASELINE CHARACTERISTICS 
 
Table 4.1: Maternal characteristics 
 
Variable 
Chlorhexidine 
(N= 59) 
n   ( % ) 
Sterile water 
(N=61) 
n  ( % ) 
P value 
Maternal Age (yrs)¶ 25 ± (4.5) 24.6 ±(4.4) 0.631 
Literacy rate 27  (45.8) 31    ( 50.9) 0.710 
No.of ANC visits 3.7 (1.1) 4.0 (1.2) 0.199 
AN steroids coverage 
    Nil 
    Partial 
   Complete 
 
27 ( 45.8) 
12 (20.3) 
20  (33.9) 
 
34 (62.3) 
10(16.4) 
17(27.9) 
0.574 
Mode of delivery 
   Normal vaginal 
   Instrumental 
   LSCS  
   
 
30 (50.8) 
8   (13.6) 
21 (35.6) 
 
24 (39.3) 
4   (6.6) 
33 (54.1) 
0.099 
ROM  duration(hrs) 
(median, IQR) 
8 ( 4 ; 25) 17.5 ( 6 ; 44.3) 0.296 
Maternal infections 4 ( 6.8) 2  (3.3) 0.645 
mothers  administered 
Intra partum antibiotic 
prophylaxis  
13  (22) 12  (19.7) 0.925 
 
¶- mean (S.D), AN – Antenatal,  ROM – Rupture of Membranes 
  
 Maternal characteristics like age, educational status, antenatal care, mode 
of delivery, underlying maternal infection were comparable between the groups. 
Mothers who were covered with antenatal steroids and intrapartum antibiotic 
prophylaxis were distributed equally between the groups.  Mothers with fever, 
urinary tract infections and chorioamnionitis were comparable in numbers in 
both the groups. 
Table 4.2: Maternal Socio- economic status  
Socio- economic 
status 
Chlorhexidine 
(N= 59) 
n   ( % ) 
Sterile water 
(N=61) 
n      ( % ) 
p- value 
Upper                (I) 0     (0)  0      (0) 0.011 
Upper middle   (II) 14  (23.7) 26    (42.6) 
Lower middle  (III) 33  (55.9) 32    (52.5) 
Upper lower    (IV) 12   (20.3)                        3 (4.9) 
Lower             (V) 0     (0) 0      (0) 
            
 Among the demographic characteristics, the socioeconomic status of the 
mothers scored using the modified Kuppuswamy scale was different between 
the two groups.  
     More number of mothers of the infants who were randomly allocated to the 
intervention (chlorhexidine) group belonged to the lower socioeconomic class 
than the mothers of the infants allocated to the placebo group. Difference in 
distribution was statistically significant      (p = 0.011) across the five classes 
(Table 4.2). 
Cause for Preterm delivery 
 The most common cause for the preterm delivery was spontaneous onset 
of preterm labour without any precipitating factors. Preterm deliveries due to 
preterm premature rupture of membranes were almost of equal incidence in 
both the groups. (Table 4.3) 
Table 4.3 Causes for Preterm delivery 
Cause of Preterm 
delivery 
Chlorhexidine 
(N= 59) 
n        ( % ) 
Sterile water 
(N=61) 
n      ( % ) 
p- value 
Spontaneous 
labour 
28     ( 47.5) 30    ( 49.2) 0.943 
pPROM  9      ( 15.3) 8      (13.1) 
Indicated 22      (37.3) 23      (37.7) 
 
Neonatal Characteristics 
          The groups were comparable in terms of mean gestational age, birth 
weights and postnatal age at recruitment. Infants born out of multiple 
pregnancies were equal in proportions in both the groups. Not many preterm 
infants had much vernix distribution on their skin (71.2 % of them with less 
than 25 % distribution) and proportion was similar in both the groups. The 
proportion of  preterm babies requiring resuscitation at birth were comparable  
in  the intervention and the control groups respectively (Table 4.4). 
 
Table: 4.4 Baseline neonatal characteristics. 
Variable Chlorhexidine 
(N= 59) 
     n     ( % ) 
Sterile water 
(N=61) 
     n     ( % ) 
P value 
Gestational 
Age wks ¶ 
 32.5     (1.8)  32.5     (1.8) 0.875 
 Birth weight  
(gms)¶ 
1691.7   ( 403.7) 1766      (425.7) 0.325 
Age at  
recruitment  
(mins)¶ 
197.7   (96.4) 167.8   (98.8) 0.096 
 Males 25         (42.5) 33          (54.1) 0.270 
Multiple births 17       (28.8) 12        (19.7) 0.339 
Vernix    
< 25 (%) 
 25 – 50 (%) 
 
42        (71.2) 
17        (28.8) 
 
36        (59.0) 
25        (41.0) 
 
0.228 
Neonates 
resuscitated at 
birth 
12      (20.3) 10        (16.4) 0.598 
 
¶- mean (S.D) 
                         
  
Table 4.5: Distribution of infants across the gestational ages  
Distribution of 
gestational age 
Chlorhexidine 
n     % 
Sterile water 
n  % 
P- value 
28 – 30 wks 8    ( 13.6) 9  ( 14.8)   0.913 
31 – 32 wks 13  ( 22.0) 15  ( 24.6) 
33 – 34 wks 38  ( 64.4) 37  ( 60.7) 
 
 The distribution of infants across different gestations among the 
intervention and the control groups was similar. More mature infants 
predominated  in both the groups. ( 64.4% Vs  60.7) (Table 4.5) 
 
 
Figure 15. Distribution of infants across the gestational ages 
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Table 4.6: Distribution of birth weight of infants  
Distribution of  
Birth weight (gm) 
Chlorhexidine  
     n    % 
Sterile water  
     n   % 
P- value 
1000 – 1499 21   ( 35.6) 17   ( 27.9) 0.290 
1500 – 1999 26   ( 44.1) 24   ( 39.3) 
2000– 2499 11   (18.6) 15    ( 24.6) 
≥  2500 1     ( 1.7) 5     ( 8.2 ) 
 
 Both the study groups had comparable distribution of birth weight 
groups. Larger neonates were more in the placebo group but was statistically 
insignificant (p=0.290) (Table 4.6). 
 
Figure 16. Distribution of birth weight 
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Table 4.7: Intrauterine growth status of the infants  
 
Intrauterine 
growth status 
Chlorhexidine 
n      % 
Sterile water 
n    % 
P- value 
AGA 42 (71.2) 47 ( 77.0) 0.588 
SGA 15 ( 25.4) 11  ( 18.0) 
LGA 2   ( 3.4) 3  ( 4.9) 
 
AGA- appropriate for gestation  
SGA- small for gestation  
LGA- large for gestation. 
 The intrauterine growth status of the preterm infants was comparable in 
both the groups. Majority of them were appropriate for gestational age (Table 
4.7) 
  
Table 4.8: Postnatal risk factors for skin colonisation  
    Variable Chlorhexidine 
(N=59) 
  n           ( % ) 
Sterile water 
 (N=61) 
n                  ( % ) 
 
P value 
Mechanical 
ventilation 
  
16             ( 27.1) 24           ( 39.3) 0.220 
Ionotropic support 10             (17.2) 15            (24.6) 0.420 
Intravenous access 
  
IV access duration 
¶ 
36             (61.0) 
 
8             (5- 15.6) 
43            ( 70.5) 
 
7            ( 5 ; 15 ) 
0.812 
 
0.774 
 
 PICC line insertion   
  
 PICC line duration 
¶ 
 
12             (20.3) 
 
6.5            (5 - 8) 
 
12            (19.6 ) 
 
6.5           ( 5 ; 8 ) 
 
0.891 
 
0.887 
Umbilical  line  
access 
 
 UVC line  duration 
¶ 
3               (5.08) 
 
 
4                 (3- 5) 
4            (6.55) 
 
 
4            (3.2-5.5) 
0.963 
 
 
0.857 
Surfactant therapy 
 
10             (16.9)  17        (27.9) 
 0.225 
¶ -Median (interquartile ranges) in days 
 The postnatal risk factors which predispose to skin colonisation like 
mechanical ventilation, ionotropic support, venous access through central and 
peripheral lines and surfactant therapy were comparable in both the groups. (p 
>0.05) (Table 4.8). 
  
Primary outcome variable 
Skin colonisation rate in the axilla after the intervention 
Table 4.9 : Positive skin culture rates in the axilla 
Time 
 
Chlorhexidine 
 
n      ( %) 
 
Placebo 
 
n       (%) 
RR 
(95% C.I ) 
P value 
 
Day – 7 
 
   22/55  (40.0) 
 
   45/56  (80.3) 
 
0.50  
(0.44-0.56) 
 
<0.001 
 
 The skin colonisation rates after the intervention on day-7 of life were 
40.0% and 80.3% in the chlorhexidine and sterile water groups respectively. 
The reduction in skin colonization was statistically significant (P < 0.01).The 
risk of colonization was reduced in the chlorhexidine group by 50% after 
multiple cleansings as compared to sterile water cleansing. The absolute risk 
reduction was 40.3%. Thus the number needed to treat was 2 persons. (NNT=2) 
(Table 4.9). 
  
  
Secondary outcome variables 
Skin Colonisation during various time lines. 
Table 4.10 : Positive skin culture rates in axilla during 48 hrs  
 
  
 
 
 
 
The skin colonisation rate at axilla was higher at the baseline in the 
chlorhexidine group by 20.1% than the placebo group. This difference was 
statistically significant.  Colonisation rates were higher in the placebo group 
thereafter. The difference in colonization observed among the groups at 48 
hours was significant (p<0.001). Even after single cleansing chlorhexidine 
group showed a reduction of 28.1% in the colonisation rates. The risk of skin 
colonization at the axilla was reduced by 33% in the chlorhexidine group at 48 
hours after a single cleansing. (Table 4.10). 
 
 
 
 
Time 
Chlorhexidine 
n        ( % ) 
 
Placebo 
n          (%) 
RR 
(95%  C.I) 
P value 
Baseline    38/59     (64.4)    27/61    (44.3) 1.45  (1.15, 1.74) 0.027 
24 hrs    37/58     (63.8)    43/57   (75.4) 0.85  (0.77, 0.93) 0.175 
48 hrs   31/55     (56.4)  49/58     (84.5)  0.67 (0.59, 0.75) <0.001 
Table 4.11: Positive skin culture rates in the groin 
 
Time 
Chlorhexidine 
   n        ( % )    
Placebo          
   n          ( %)  
RR   (95% C.I) P value 
Baseline  35/59    (59.3)  21/ 61   ( 34.4 ) 1.72 (1.23, 2.21) 0.006 
24 hrs  33/58    (56.9)  44/57    (77.1) 0.74  (0.66 ,0.82 ) 0.021 
48 hrs  34/55    (61.8)  50/58    (86.2) 0.72  ( 0.64 ,0.81) 0.002 
Day – 7  28/55    (50.9)   46/56    (82.1) 0.62   (0.55, 0.71) <0.001 
 
 The skin colonisation rate after the intervention on day-7 of life was 
50.9% and 82.1% in the chlorhexidine and sterile water groups respectively. 
The difference in the skin colonization rates was statistically significant (P < 
0.01). The absolute risk reduction was 31.2%. Thus the risk of colonisation in 
the groin was reduced by 38%   on the seventh day of life after repeated 
chlorhexidine cleansing. The number needed to treat with this reduction was 3 
persons at the groin (NNT=3). The colonisation rates in the groin in the 
intervention group at 24hours, 48hours and on day 7 were all significantly lower 
than the placebo group in the groin. (Table 4.11) 
 The skin colonisation rates in the groin remained higher than the axilla 
during the study period except at baseline. 
 
 
 
Bacterial colony counts in the culture positive swabs 
Table 4.12 : Colony counts in the axilla during the study period 
Time 
Chlorhexidine 
n    median (IQR) 
Placebo 
n     median (IQR) 
P value 
Baseline 59    10
2
    (0 – 103) 61      0      (0 – 103) 0.098 
24 hrs 58   10
2.7
 (0 – 104) 57     103   (101.7-104) 0.351 
48 hrs 55  10
2
    (0 – 104) 58     103  (102 -104) 0.011 
Day 7 55   0        (0-10
3
) 56     10
 4
 (10
2 
-10
5
) < 0.001 
 
able 4.13 : Reduction in the colony counts in the axilla  
Time 
Chlorhexidine 
n  median (IQR) 
Placebo 
n    median  (IQR) 
p- value 
 
0 – 24 hrs 58  0(104 to -102) 57  102 ( 104 to 0) 0.164 
24-48 hrs 55  0(10
3
 to -10
3
) 55  0  (10
3
 to -10
2
) 0.366 
48 hrs – D7 53 0(0 to -103) 53 0 (105  to -102.7) 0.006 
0 –  D7 53  0(0  to -103) 52   103  (105  to  0) <0.001 
 
 The   median colony counts taken at 48 hrs (10
2
 and 10
3
, p=0.006) and on 
the seventh day of life (0 and10
4
, p<0.001) from the axilla were significantly 
less in the chlorhexidine group than the sterile water group.(Table 4.12). The 
quantitative reduction from the baseline on day – 7 of life was significant 
between the groups. (Table 4.13). 
 
Table 4.14 :  Colony counts in the groin during the study period 
 Time 
n 
Chlorhexidine 
median   (IQR) 
n 
       Placebo 
 median (IQR) 
P value 
Baseline 59     10
2 
    (0 to 10
3
)       61           0    ( 0 -10
3 
) 0.041 
24 hrs 58     10
2
     ( 0 -10
4
) 57          10
3
   (10
2
 -10
4 
) 0.042 
48 hrs 55     10
2
     (0 -10
4
) 58          10
4     
(10
2 – 105) 0.004 
Day-7 55     10
1.7
   (0 – 103.9) 56          104  (102- 105) 0.000 
 
 The median colony counts in the chlorhexidine group were significantly 
lower than that of sterile water at 24 hours (10
2
 and 10
3
,p=0.042), 48 hours(10
2
 
and 10
4
, p=0.004) and on the seventh day of life (10
1.7
 and 10
4
, p<0.001) in the 
groin. (Table 4.14)                                                                                                                  
 
 
 
 
 
 
 
 
 
Table  4.15 :  Reductions in colony counts in the groin during the study 
period 
 
Groin 
Chlorhexidine 
 n     median   (IQR) 
Placebo 
  n     median  (IQR) 
p-
value 
0 - 24 hrs 58     0 (10
2.6
 to -10
2 
)  57  10
2
 ( 10
4
 to 0 ) 0.030 
24 - 48 hrs 55     10
4 
( 0 to -10
5
)  55    0 ( 10
4
 to 0 ) 0.094 
48 hrs – D7 53       0 ( 0 to -103 )  53  0 (-103  to -103.7)  0.107 
0 - Day 7 53    0 ( 10
3
 to -10
3
 )  52    10
3
 ( 10
5
 to 0 ) 0.000 
  
 The reduction in the colony counts at 24 hrs (0 and 10
2
, P= 0.030) and 
day seven (0 and 10
3
, P<0.001)  from the baseline were significant in the 
chlorhexidine group as compared to the placebo group. (Table 4.15)   
.  
Table 4.16 : Outcomes on Follow up  
Status on D- 28 
Chlorhexidine 
(N=58) 
n      ( % ) 
Sterile water 
(N=60) 
n        ( % ) 
P value 
Mortality 6      (10.1) 10       (16.3) 0.451 
Discharged 44     (74.5 ) 42       (68.8) 0.621 
Sick in hospital 0       (0) 7       (11.7) 0.007 
Repeat 
hospitalisation 
0      (0) 6         (14.6) 0.029 
 
 There was no significant difference in mortality rates between the infants 
in the chlorhexidine and the sterile water groups. The discharge rates among 
both the groups were similar. There were 8 infants in the chlorhexidine group 
who remained in the hospital for weight gain. The number of infants who were 
sick on Day 28 and the proportion that required repeat hospitalisation were 
significantly lower in the intervention group. (Table 4.6). 
 
 
 
 
 
 
Table 4.17 :  Incidence of sepsis during the first week 
Gestational age 
weeks 
 
N 
Chlorhexidine 
 
 n     ( % ) 
 
N 
Sterile water 
 
n       ( % ) 
P 
value 
          28 -   34 
 
28 - 31  
 
 32 - 34  
 
59 
 
15 
 
44 
 
 
17   ( 28.8)  
 
  6    (40.0) 
 
  11   (25.0) 
 
 
61 
 
16 
 
45 
 
 
23    (37.7) 
 
12   (75.0) 
  
11   ( 24.4) 
 
0.401 
 
0.048 
 
0.952 
 
 Out of 120 neonates 59 underwent septic workup.18 patients had culture 
positivity (30.5%) and 22 infants had septic screen positive or clinical course 
suggestive of septicaemia. 
  Two infants in the sterile water group had meningitis and none in the 
chlorhexidine group. 4 cases of skin infection were (IV site abscess) observed in 
the sterile water group. Though overall sepsis rates were not different between 
the two groups, on subgroup analysis less mature infants (28 – 31 weeks GA) in 
the placebo group had higher incidence of sepsis than their counterparts in the 
chlorhexidine group. (Table 4.17). 
  
Table 4.18 : Mean skin temperatures during cleansing  
Cleansing Time 
( min) 
Chlorhexidine 
mean ( S.D) 
Sterile water 
mean  (S.D) 
P- value 
 
First 
0 
5 
15 
36.5(0.1) 
35.7(0.8) 
36.5(0.1) 
  36.5 (0.1) 
35.9 (0.5) 
36.5 (0.1) 
1.000 
0.281 
0.501 
Second 0 
5 
15 
36.4 (0.4 
35.9(0.6) 
36.4 (0.3) 
 
36.4 (0.2) 
36.0 (0.5) 
36.4(0.3) 
 
0.890 
0.322 
0.762 
Third 0 
5 
15 
 
36.4 (0.3) 
36.1 (0.5) 
36.4 (0.3) 
36.3 (0.3) 
36.0 (0.5) 
36.3 (0.3) 
0.440 
0.583 
0.928 
 
 
 Mean skin temperatures at baseline, 5 and 15 minutes after all the three 
cleansing procedures were comparable between the two groups. Though there 
were variations in the mean temperatures within the groups it was  comparable  
between  the  groups  in  both  the  sub  groups. (Table 4.18).  
 
 
 
 
 
Table 4.19 : Incidence of cold stress and hypothermia during cleansing 
Wipe Time 
(mins) 
Chlorhexidine 
 n     (%) 
Placebo 
 n   ( %) 
P value 
First 0 
5 
15 
0      (0) 
27   (45.8) 
0      (0) 
0      (0) 
26    (42.6) 
1      (1.6) 
- 
0.87 
1.000 
Second 0 
5 
15 
2      (3.5) 
22 (37.9) 
3     (7.4) 
2      (3.3) 
21    (35.0) 
5      (8.3) 
1.000 
0.889 
1.000 
Third 0 
5 
15 
3     (5.4) 
17   (30.4) 
3 (5.4) 
1    (8.8) 
18  (31.6) 
4    (7.0) 
0.733 
1.000 
1.000 
 
 The proportion of the patients who slipped into the cold stress and 
hypothermia gradually decreased as the postnatal age advanced. There was no 
significant difference in proportion of patients who experienced cold stress and 
hypothermia between the two groups (Table 4.19). 
Comparison of skin condition scores  
 The skin condition of the infants  cleansed with chlorhexidine were not 
different from that of the infants cleansed with sterile water. Skin changes like 
erythema, drying, scaling or fissuring were not observed in any of the infants in 
both the groups.  
 
 
 
 Table 4.20 : Gram Negative organism colonisation 
Site / time Chlorhexidine 
n         % 
Placebo 
n          % 
P- value 
Axilla-baseline 17     (44.7) 9       (33.3) 0.355 
Axilla -24 hrs  22     (59.5) 29     (67.4) 0.459 
Axilla- 48hrs 18     (58.1) 35     (71.4) 0.218 
Axilla- day 7 9      (40.9) 23     (51.1) 0.432 
Groin-baseline 11    (31.4) 9       (42.9) 0.405 
Groin -24 hrs  19   (57.6) 33     (75.0) 0.106 
Groin - 48hrs 24    (70.6) 32     (64.0) 0.530 
Groin- Day 7 17    (60.7) 25   (54.3) 0.592 
 
 Colonisation with gram negative pathogens were comparable in both the 
groups (Table 4.20). 
 
Figure 17 : Frequencies of the Gram Negative organisms 
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DISCUSSION 
  
DISCUSSION 
 
Characteristics of the study population     
 In our study we enrolled 120 haemo dynamically  stable  preterm infants 
whose  mean  gestational age  and birth weight were 32.5 (±1.8) weeks and 
1700 (± 403) grams  comparable in both the intervention and placebo groups. 
No sex predominance was observed. Majority of them were recruited at a mean 
postnatal age of 3 hours. 
 The study population in the previous trials
12,48,52
 were dominated by the 
mature term neonates and their conclusions on efficacy and safety profile of 
chlorhexidine in neonatal medicine may not be applicable to the vulnerable 
preterm population. Hence M.J Sankar et al
53
 studied the preterm population 
exclusively enrolling 28-36 weeks GA infants weighing 1000-2000 grams at 
birth.  They sampled a relatively small number of preterm infants (20   infants in 
the intervention and 20 in control groups). 
 The baseline parameters of the mothers were also comparable. The 
proportion of infants delivered by vaginal route was 53%. All but one (the 
socioeconomic status of the mothers classified according to the modified 
Kuppuswamy classification, (Annexure 5) were comparable between the 
groups. The socioeconomic status of the mothers showed a significant 
difference. Previous studies did not include the socioeconomic status in the 
demographic profile. We speculate that this would have a bearing on the 
maternal vaginal colonisation due to the poor hygienic status prevailing in the 
lower socioeconomic class.  
 The postnatal risk factors which favour skin colonisation like respiratory 
and inotropic support, surfactant therapy and venous access through peripheral 
and central lines were comparable between the groups. 
Skin colonisation  
 In our study, multiple whole body cleansings with 0.5% chlorhexidine 
showed significant reduction in the skin colonisation rates on day seven of life 
in the axillary and groin regions as compared to cleansing with sterile water. 
The risk of colonisation was reduced in the axilla by 50% and groin by 38% 
with three applications of 0.5% chlorhexidine. Higher percentage of reduction 
was produced by chlorhexidine in the axilla than in the groin. 
            Not many studies had looked at skin colonisation at the end of the first 
week but for the one conducted by Gary Darmstedt et al 
52
 among the out born 
hospitalised neonates. This study evaluated the impact of a single application 
0.25% chlorhexidine. This trial could not achieve reduction in the skin 
colonisation on day seven though it claimed an extended antiseptic effect until 
72 hours differentially in various sites.  
 Our study was able to achieve a sustained reduction in skin colonisation 
during the first week. It was the first one to demonstrate the impact of 
chlorhexidine after multiple applications. The biological rationale for this was 
the substantivity of chlorhexidine which would last 48 hours
40
. A single 
application at birth may not produce a sustained effect until one week. This fact 
is also substantiated by the conclusion from the latest systematic review (2013) 
on this topic.
55
  
 Multiple cleansings with chlorhexidine was able to achieve greater 
reduction in colonisation (50%) than a single application (33%). There seems to 
be a cumulative effect in reduction of colonisation with multiple applications. 
This reduction in colonisation during the first week may offer long-standing 
protection against the transcutaneous route of entry. 
  A significant reduction in the colonisation rates could not be achieved at 
24 hours after a single application both in the axilla and groin regions. However 
a single application of 0.5% chlorhexidine was able to reduce skin colonisation 
by 33% and 28% in the axilla and groin respectively at 48 hours. Our study 
demonstrated a quantitative reduction in colony counts also in the culture 
positive swabs at 48 hours and on the seventh day 7 in the axilla and groin 
which was statistically significant. 
           In a hospital based study in Bangladesh 
52
 at 24 hours colonisation was 
significantly less with chlorhexidine in both axilla and groin. The study 
included larger, mature neonates (mean B.W= 3000gms) who would possess 
better skin maturity and are at less risk of nosocomial skin colonisation. They 
excluded infants weighing less than 1500 g who are predisposed to nosocomial 
colonisation and sepsis due to their longer hospital stay.        
 The study
48
 in Nepal among hospital born newborns demonstrated 48% 
and 50% reduction in the risk of colonisation with 0.25% and 0.5% 
chlorhexidine respectively at 2 hours after single application. Since more than 
50% of neonates were discharged earlier it could not report significant reduction 
at 24 hours. There was a dose response trend on skin colonisation. The highest 
concentration (1%) achieved 63% reduction followed by 0.5% achieving 50% at 
2hours.  
 But both the concentrations could not achieve reduction at 24 hours, a 
period when the skin colonisation in neonates increase exponentially after birth.  
The study at AIIMS among the preterm population
53
 reported 60% reduction in 
the axillary colonisation at 24 hrs after using 0.25% chlorhexidine. There was 
no significant reduction in the groin. 
 Thus the results have been variable and inconclusive in the literature. We 
understand from the previous trials that 0.25% concentration of    chlorhexidine 
did not achieve a reduction in skin colonisation consistently after a few hours. 
 We were able to achieve significant difference in the colonisation after a 
single application consistently both in the axilla and groin even at 48hours. 
Using chlorhexidine at higher concentration (0.5%) achieved additional efficacy 
and greater residual activity.  A 50% reduction in the risk of colonisation by 
0.5% chlorhexidine in the study conducted by Luke C Mullany et al in Nepal
48
 
was similar to our result. The increased efficacy of higher concentrations of 
chlorhexidine is explained rationally by its bactericidal action at higher 
concentrations
40
.  
 In our study the difference in skin colonisation between the placebo and 
intervention groups was not significant at 24 hours. We speculate that the 
natural exponential increase 
(3,33)
 in skin colonisation rates after 12- 24 hours in 
both the study groups would not have allowed to achieve significant difference 
between them.  
 This is evidenced by the increase seen in colonisation rates in the placebo 
group above the baseline at 24 hours compared to the chlorhexidine group. Also 
some of the previous studies were not able to show reduction in the rates at 
24hrs after the reduction achieved at 2 hours due to the rebound increase in 
colonization
(48,54)
. At 48hours the colonisation in the placebo group increased 
unintervened as compared to the decreased colonisation in the intervention 
group. Hence at 48 hours there was a statistically significant difference between 
them.  
 The axillary colonisation rate was initially higher than the groin at 
baseline. Subsequently colonisation rates increased in the groin. A logical 
explanation would be that the axilla would be handled more frequently at 
admission in the process of transportation from the labour ward to the NICU, 
during weighing and various procedures of care and treatment. Afterwards groin 
area gets contaminated more by flora from nearby perineum and hands of the 
caregivers during the process of changing diapers. The higher concentration of 
chlorhexidine used in our study produced consistent results in both the areas 
studied. This concentration was effective even in the inguinal region.  
           We did not study the peri umbilical colonisation .Few studies included 
periumbilical region also
(48,52)
. Many times skin probes are attached to this 
region with adhesives and may interfere with the results and hence was not a 
choice in our study.  
          Though the babies are considered to be sterile at birth and colonisation 
only gradually increases from 6-12 hrs of postnatal life 
(3,33)
, the baseline skin 
colonisation in the control group in the axillary and groin regions were 44.3% 
and 37.5% respectively. This is similar to the baseline line smears reported in 
the AIIMS trial (30% & 40%). The baseline growth in the intervention group is 
higher than the  placebo group at both the axillary (64.4%) and inguinal (62.5%) 
sites.  
 The studies conducted by Luke C Mullany et al
48
 in  inborn neonates and 
Gary L Darmstadt et al
52 
in out born neonates  admitted to the unit within 72 hrs 
have reported  similar rates of colonisation at the baseline.  
 The baseline colonisation in the chlorhexidine group was significantly 
higher than the placebo groups unlike the other studies. This could be due to the 
unequal distribution of the mothers of different socioeconomic strata in the two 
study groups. The higher proportion of mothers of  lower socio economic class  
were in the chlorhexidine group as compared to the placebo group. The poor 
hygienic status of the mothers in the lower socioeconomic class could have 
predisposed to the higher baseline skin colonisation in the chlorhexidine group. 
Mortality rates and incidence of sepsis  
 The Neonatal mortality rate and the incidence of sepsis were not different 
in both the study groups.  Before and after studies done in Egypt
54
 and Malawi
13
 
hospitals and the communities in Nepal
12
 were able to show a reduction in 
neonatal mortality with the chlorhexidine intervention. But later studies which 
were randomised controlled trials like ours were not able to show a reduction.  
            A systematic review (2013)
55
 of these studies concluded that a single 
application may not produce an effect on the mortality rates and incidence of 
sepsis. Repeat hospitalisation rates and the proportion remaining sick on day -28 
of life were significantly lower in the experimental group. The reduction in skin 
colonisation achieved with multiple applications of chlorhexidine in our study 
did not get translated as reduction in mortality and sepsis rates in the infants. A 
study with a larger sample size may produce a difference. 
           However there was a reduction in the incidence of sepsis in the more 
immature infants between of 28 - 31 weeks of gestation GA in the subgroup 
analysis. This is clinically relevant and important because in the smaller preterm 
infants the transcutaneous route of entry is likely to be more common than the 
mature ones and chances of sepsis caused by resident micro flora of the skin 
like CoNS is more prevalent in this group
13
. Thus these immature preterm 
infants with most handicaps in their defense mechanisms are likely to be 
benefitted by the antiseptic action of chlorhexidine.  
Safety profile of chlorhexidine 
           Our study showed that the concentration of chlorhexidine at levels of 
0.5% was well tolerated by the preterm neonates. The reports from our study 
demonstrate the safety profile of chlorhexidine in preterm neonates even after 
multiple applications in terms of temperature stability and skin integrity. 
 The incidence of cold stress and hypothermia was not significant in our 
study population. The latest systematic review (2013) quoted on this topic that 
hypothermia was a significant concern with chlorhexidine application in the 
preterm infants.
55
  Our babies were cleansed most of the times under radiant 
warmers and rarely in the postnatal wards. Previous studies by Darmstadt and 
Sankar 
52, 53
 done under similar conditions have also not reported significant  
hypothermia.  
           There were no signs of erythema, fissuring or dryness in the skin. Skin 
condition scores even after repeated cleansing were similar to the baseline 
scores in both the study groups. The chlorhexidine was used in the aqueous 
form avoiding the alcohol which could have been the culprit for the skin burns 
and erythema as previously reported in the literature
43
. There were reports of 
chlorhexidine causing dermatitis only when it was impregnated in the dressings 
placed over catheter sites restricting the capillary perfusion at that site
57
.  Few 
ELBW infants developed erythema and 3 or 4 infants had skin break down and 
exudation with a high concentration of chlorhexidine in the study by Bringue et 
al
 46 
(2%). There were no reports of contact dermatitis when chlorhexidine was 
used for whole body cleansing, in aqueous form and in 0.5% concentration even 
in the earlier studies.
 (48,52,53) 
 
Skin colonisation profile 
 
 It was feared initially that multiple applications of chlorhexidine would 
ironically increase the sepsis rates because reduction in the resident flora might 
predispose to colonisation by pathogenic, nosocomial gram negative organisms. 
This effect could be compounded much more due to the fact that chlorhexidine 
was chosen to be applied in the aqueous form without alcohol, losing the cidal 
effect of alcohol on the gram negative organisms
45
. It was found not only to be 
safe but also did not increase the risk of nosocomial gram negative colonisation 
.  
Systemic absorption of chlorhexidine 
 The systemic absorption of chlorhexidine was not assayed in our study. 
Systemic absorption in preterm infants exposed to chlorhexidine would be a 
significant area of concern because the thin epidermal layer is ineffective in 
protecting against the absorption of toxic substances applied topically. There are 
no established values for what is considered to be a safe concentration of 
chlorhexdine in the blood
57
. 
  However we limited our applications to three in the study since the much 
feared neurotoxicity in the hexachlorophene usage through systemic absorption 
from the skin was reported after four or more applications
47
. The alcohol that is 
known to potentiate the absorption of topically applied chlorhexidine
49
 was also 
avoided in our study. We skipped the areas like face and scalp which are highly 
vascular
3
 and would increase the chances of systemic absorption. Even then to 
document its safety with a full proof a long term neuro developmental   follow 
up of the infants may be necessary. None of the studies in the literature also 
have attempted to study this aspect of its safety profile
57
. 
  
Strengths of the study  
 Our study came up with a new idea of multiple applications of 
chlorhexidine based on its property of substantivity for the first time in neonatal 
medicine.  
 Our study is the first RCT with a large sample size in preterm population.  
 The double blinding was full proof eliminating treatment and 
measurement bias.  
 The higher concentration  of chlorhexidine demonstrated the sustained 
reduction in skin colonisation for the entire first week consistently in both the 
areas studied.  
Limitations of the study 
 Failure to assay the serum levels of chlorhexidine after multiple 
applications would be an important limitation of our study. 
 The study did not report on the neurodevelopemental outcome of the 
infants to detect any potential neurotoxicity. 
   
                                           
 
 
 
  
 
 
 
 
          CONCLUSION   
 CONCLUSIONS 
1) Multiple applications of 0.5% chlorhexidine reduced the risk of  skin 
colonisation in the axilla and groin by 50% and 38%  respectively during 
the first week (NNT = 2). 
 
2) A single application of 0.5% chlorhexidine at 48 hours reduces the 
 risk of skin colonisation by 33% and 28% in the axilla and groin 
 respectively.  
 
3) The results of quantitative reductions in the bacterial colony counts  in 
the axilla and the groin at different time points were also similar. 
 
4) There was no difference in mortality on the 28 – day of life  between 
the two groups.  
 
5)  There was no significant difference in the incidence of sepsis  during 
the first week of life between the groups. But the incidence  of sepsis in the 
28-31 weeks GA infants was lower in the  chlorhexidine group.  
 
6) Rate of repeat hospitalisation and the proportion remaining sick on 
 day – 28 of life were significantly lower in the intervention group.  
 
7) Multiple applications of 0.5% chlorhexidine in the aqueous form 
 was well tolerated by the preterm infants without skin toxicity and 
 thermal instability. The aqueous preparation did not predispose to 
 skin colonisation with gram negative organisms. 
  
 
Implications for practice 
Preterm neonates admitted in the NICUs  may benefit from skin cleansing with 
0.5% Chlorhexidine wipes every alternate day during the first week to reduce 
skin colonisation. 
Implications for research 
 1)  The neurodevelopemental outcome of the preterm neonates  cleansed 
 with chlorhexidine in the nurseries should be studied  on a long term 
follow up.  
2)  The synergistic effect of combining neonatal intervention with  maternal 
vaginal cleansing during delivery can be studied.  
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Annexure - 2 
Data collection and entry form 
  
Name:                                     Serial no:                               Study random no:                             
Infant Details 
IP no:        Disc no:   Address: 
Date / time of admission 
Date / time of Birth      
Date / time of recruitement            Contact Phone no. 
 
Gestational age by dates :  USG:    NBS 
Birth weight:  gms  ( AGA /SGA /LGA) 
Sex: 
Mode of delivery: 
Resuscitation details:  Routine/ initial steps/ O2 /BMV/ intubation / chest comp             
Post resuscitation:   Respiratory   =   O2 / CPAP/ mech ventilation 
    Circulatory    =    Inotropes 1/ Ionotrope 2 / Adrenaline  
                                    Encephalopathy   =     Yes / no 
Skin defects:       Vernix: 
 
 
Major congenital malformations: 
Sepsis Score: 
Empirical antibiotics:     Yes / No 
Immediate referrals : 
Maternal details 
Serial no: 
Name of the mother & Father  Monthly income: 
IP no:     Educational status of father: 
Age:     Educational status of Mother:  
ANC :                    visits:     Occupation:  
Date of admission:    Socio economic Status 
Date of delivery: 
LMP: 
EDD: 
Gestational age by dates: 
Gestational age by USG 
Gestational illness:    GDM/ PIH /Anemia / others  
Drug intake: 
Reason for Prematurity:     Labour induction: 
ANCS details: 
Risk factors for EOS  
i. Maternal fever 
ii. lower abdominal pain / Dysuria  
iii. PROM 
iv. Foul smelling liquor 
v. No of PV 
vi.  Fetal tachycardia 
vii. Duration of labour 
viii. e/o fetal distress,  Meconium stained liquor 
ix. Intrapartum Antibiotics 
 
   Placenta:  
 
NEWBORN    SKIN   CONDITION    SCORES 
 At birth Before 2nd 
wipe 
Before 3rd 
wipe 
End of study 
Date     
Time     
Score     
 
AXILLARY TEMPERATURE 
After 
wash 
Date Time O min 5 min  15 min 
1st       
2 nd       
 3rd      
 
 
   Smear  Date Time                Axilla              Inguinal 
organism Colony  
counts 
organism Colony  
counts 
Baseline       
24 hrs       
48 hrs       
D7        
 
   
  
  
SYMPTOMS  & SIGNS OF SEPSIS with day of onset 
 
1.   (           ) 6.   ( ) 
2.   (          ) 7.   ( ) 
3.   ( ) 8.   ( ) 
4.   ( ) 9.   ( ) 
5.   ( ) 10.   0thers              ( ) 
 
 
     
Discharge / death 
  Date & Time = 
Day of life 
 
FOLLOW UP  
1.Repeat hospital admissions 
 
 
 
2.Status on Day 28 of life 
Date : 
 
  
                                                   ANNEXURE – 3A 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
                  ANNEXURE – 3B   
  
    ANNEXURE – 4 A 
CONSENT FORM 
 
Effect of Whole body cleansing with chlorhexidine on skin colonization in 
newborns. – a randomised trial  
 
Name of investigator:      Date: 
    
  Name of the patient :      Serial number: 
  
 I Ms/Mr.__________________________ M/O//F/O, B/O _______________________ 
Sex___________Hosp. No.________________ admitted in the Neonatal ICU of IOG , Egmore was 
explained by the doctor that my baby is born preterm and low birth and therefore more 
vulnerable to infections from microorganisms on the skin surface . I am willing to participate in 
this trial and I give my consent to apply chlorhexidine or sterile water on the skin using baby 
wipes as per the study  protocol. 
   I also give my consent for taking swabs from the skin needed during the study. The 
adverse effect like skin rashes, cold stress were explained to me.  
 The doctors have explained to me the nature and the purpose of the trial. I have given my 
consent only after completely understanding the details that were explained to me. I 
understand that my baby’s routine clinical management is not affected  by my participation in 
this trial. 
  I have given this consent to be enrolled in this study with my full consciousness. I am 
willing for my baby to be enrolled in this study without any ones compulsion and I am fully 
aware that I can withdraw from the trial at any time during the study. 
 
Signature of Investigator                                                                        Signature of Parent    
  
Annexure – 4B 
INFORMATION SHEET 
 
Effect of Whole body cleansing with chlorhexidine on skin colonization 
in newborns. – a randomised trial  
Name of investigator:      Date: 
   Name of the patient :      Serial number: 
     Many   microorganisms are present on the body surface of the newborn infants. The preterm Low 
birth weight infants have weak skin barrier and defense mechanisms. Hence these organisms go into 
blood and cause serious infections and death.  Chemicals like chlorhexidine can reduce or remove 
these organisms from the skin surface and protect these infants.  But details regarding appropriate 
dose, safety and clinical benefits are unknown in preterm infants. Hence we are conducting a 
scientific experiment by using chlorhexidine to decrease the surface microorganisms in preterm 
infants admitted in our newborn unit at Institute of Obstetrics & Gynaecology. 
    After obtaining your consent, your baby will be included as a participant in the trial if he/she 
satisfies our eligibility criteria. The participants will be included under one of the two study groups.  
The participants will be wiped with body wipes applying the content over the entire skin surface 
except on the face every alternate day during the first week of life (3 times). The content will be 
chlorhexidine in one study group and sterile water in the other study group. Swabs will be taken from 
the skin surface to detect and count the organisms before and after the application. The contents of the 
wipes shall not be disclosed to the caregivers and the professionals involved in the treatment and lab 
investigations. The treatment code will be broken after the analysis or in the event of life threatening 
adverse effects. 
    As known from the previous experiments, during the procedure the baby may experience cold 
stress.  The baby will be nursed under a radiant warmer, body temperature will be monitored at 
regular intervals and necessary warmth will be given appropriately. After application the skin may 
appear red, dry or breakdown. Further application will be stopped and appropriate treatment will be 
given in case of serious skin breakdown. 
      Your participation in the trial will not influence the routine clinical management necessary for the 
condition of the participant. The participants will be under follow up after discharge for one month of 
life during their visits to hospitals for medical checkups and immunizations or through telephonic 
calls.   
              The privacy of the patients in the research will be maintained throughout the study. In the 
event of any publication or presentation resulting from the research, no personally identifiable 
information will be shared. Taking part in this study is voluntary. You are free to decide whether to 
participate in this study or to withdraw at any time; your decision will not result in any loss of 
benefits to which your child is otherwise entitled. The results of the study may be intimated to you 
at the end of the study period. 
 
    Signature of investigator                                                     Signature of Parent 
  
Annexure -5 
Socioeconomic Status Scale of Kuppusamy 
(Urban 1976), Score card 
(A) Education                        score 
1. Professional  or honours     7 
2.  Graduate or post-graduate     6 
3. Intermediate or post high school diploma  5 
4. High school certificate    4 
5. Middle school certificate    3 
6. Primary school or literate    2 
7. Illiterate      1 
(B) Occupation  
1. Profession       10 
2. Semi- profession     6 
3. Clerical, shop owner,farmer    5 
4. Skilled worker     4 
5. Semi-skilled worker     3 
6. Unskilled worker     2 
7. Unemployed     1 
     (c) Family income per month( in Rs )   ( Modified for 1998) 
            )        Original  Modified  
1. >2000  >13500    12 
2. 1000-1999  6750-13499   10 
3. 750-999  5050-6749   6 
4. 500-749  3375-5079   4 
5. 300-499  2025-3374   3 
6. 101-299  676-2024   2 
7. <100  <675    1 
Total score   Socioeconomic  class 
1.26-28   upper (I) 
2.16-25   Middle   Upper middle(II) 
3.11-15   Lower middle(III)   
4. 5-10   Lower   Upper lower (IV) 
5.  <5                  Lower (V) 
Annexure - 6 
Newborn skin condition scoring scales 
       Dryness: 
- 1 = Normal , no sign of dryness 
- 2 = Dry skin , visible scaling 
- 3 = very dry skin,cracking/fissures 
     Erythema: 
- 1 = No evidence erythema 
- 2 = Visible erythema, <50% body surface  
- 3 = Visible erythema, >50% body surface 
    Breakdown: 
- 1 = None evident 
- 2 = Small, localised areas 
- 3 = Extensive  
 
Perfect score = 3 
Worst score = 9    
 
 
 
 
 
 
 
 
 
S. No. Strat coRandoGroupMaternal Name Recru age (GA days B.W Sex Mult
1 B 1 CHX srisha 180 34 1 1810 2
2 B 2 CHX  kamatchi 120 34 2 2150 1
3 B 3 PLB Vannila  135 34 1 2640 1
4 A 1 CHX Vasanthi 235 31 4 1690 1
5 B 4 PLB chandra 105 34 2 1700 2
6 A 2 PLB anitha 60 31 5 1770 1
7 A 3 CHX Jothi 360 31 0 1150 2
8 B 5 PLB chinna nagamma 90 34 3 2095 1
9 B 6 CHX Kavitha 240 34 6 1895 2
10 B 7 CHX Grace 300 32 0 1505 2
11 A 4 PLB Madina 180 31 5 1745 1
12 B 8 CHX Srimathy 240 32 6 1590 1
13 B 9 PLB Ishwarya 15 33 6 1100 1
14 A 5 CHX Jayalakshmi 360 29 2 1050 2
15 B 10 PLB Saraswathy 180 32 3 2050 1
16 B 11 PLB Kavitha 3 120 34 4 1895 1 TCTA
17 B 12 CHX Kavitha 2 120 34 4 1400 1 TCTA
18 B 13 CHX Rajeswari 60 34 0 1360 2
19 B 14 PLB Asma siddika 60 32 0 1820 2
20 B 15 PLB Asha 210 34 3 1870 1
21 B 16 CHX Ratna 90 33 0 1855 2
22 B 17 PLB Vasanthi 300 34 5 2335 2
23 B 18 CHX Patchaiammal 150 34 0 2080 1
24 B 19 CHX Amulu 60 33 4 1125 1
25 A 6 CHX Shenbagavalli 330 31 6 1120 1
26 B 20 CHX Vanaja 240 34 2 1900 1
27 B 21 PLB Suguna 60 34 6 2500 2
28 B 22 PLB Malarkodi 180 34 5 1855 2
29 A 7 PLB Kokila 120 31 6 1140 2
30 B 23 PLB Divya Bharathi 60 32 5 1450 1
31 B 24 PLB Indumathy 300 34 4 2510 1
32 A 8 PLB Sofiamary 60 31 6 1230 1
33 B 25 CHX Jeyashree 120 32 6 1890 2
34 B 26 CHX Prasanna 1  180 33 4 2295 2 MCMA
35 B 27 CHX Prasanna 2 180 33 4 2160 2 MCMA
36 B 28 PLB Puspalatha 1 300 34 2 2225 2 MCDA
37 B 29 PLB Puspalatha 2 300 34 2 2240 2 MCDA
38 B 30 CHX Kamala 240 32 4 1820 2
39 B 31 CHX Nithyamalli 360 33 6 1920 2
40 B 32 PLB G0wsiya begam 210 34 5 2025 2
41 B 33 CHX Sudha 120 32 2 1660 1
42 A 9 CHX Subbalakshmi 1 120 29 2 1315 2 MCDA
43 A 10 PLB Subbalakshmi 2 120 29 2 1270 2 MCDA
44 B 34 CHX Muzhumathi 60 34 3 2990 2
45 B 35 PLB Nithya 300 34 0 2075 1
46 B 36 PLB Usha 1 60 33 4 1580 2 MCDA
47 B 37 PLB Usha 2 60 33 4 1665 2 MCDA
48 A 11 PLB Kavitha 300 31 2 1135 1
49 A 12 CHX Janaki 180 28 4 1100 1
50 B 38 PLB Usha 180 32 5 1815 2
51 B 39 CHX Vanaja 90 34 0 1940 2
52 B 40 CHX Sivasakthi 330 34 5 2000 2
53 B 41 PLB Bharathi 2 180 34 2 1300 2 DCDA
54 B 42 CHX Bharathi1 180 34 2 2045 2 DCDA
55 B 43 PLB Malathy 120 34 0 1900 1
56 A 13 CHX Bama 120 31 6 1165 2
57 B 44 CHX Asha 1 260 33 5 1660 2 MCMA
58 B 45 CHX Asha 2 260 33 5 1420 2 MCMA
59 A 14 PLB Chithra  2 360 31 5 1070 2 DCDA
60 A 15 CHX chithra 1 360 31 5 1550 1 DCDA
61 B 46 PLB Nagendra mani 105 33 0 1660 1
62 A 16 PLB Dhanalakshmi 120 30 5 1185 2
63 B  47 CHX Poongavanam 1 300 33 5 1380 2 MCDA
64 B 48 CHX Poongavanam2 300 33 5 1245 2 MCDA
65 B 49 PLB shruti 240 33 5 1900 2
66 A 17 CHX Sheerin 1 60 30 1 1430 1 MCDA
67 A 18 PLB Sheerin 2 60 30 1 1345 1 MCDA
68 B 50 PLB Ambika 80 34 0 2090 1
69 A 19 CHX Jayanthi 90 31 1 1655 1
70 A 20 PLB Ammu 120 30 1 1330 2
71 B 51 CHX Indra 240 34 4 1715 1
72 A 21 PLB Bharathi 2 315 29 5 1300 1 MCDA
73 A 22 CHX Bharathi 1 315 29 5 1740 1 MCDA
74 B 52 CHX Boomadevi 360 33 3 2300 1
75 B 53 PLB Easwari 295 33 2 2510 1
76 B 54 PLB Thulasi 180 32 7 1500 1
77 B 55 PLB Parimala 330 34 5 1930 2
78 B  56 PLB Sumathy 150 34 4 2365 2
79 A 23 CHX Karthiga selvi 180 28 2 1190 1
80 B 57 CHX Karishma 120 34 2 1955 1
81 B 58 CHX Kaliyammal 40 33 4 1050 2
82 A 24 CHX lakshmi 300 30 2 1365 1
83 B 59 PLB Chandrammal 240 33 0 2115 2
84 B 60 CHX Saranya 270 33 0 1685 1
85 B 61 PLB Indumathy 2 75 34 4 2040 2 DCDA
86 B 62 CHX Indumathy1 75 34 4 2360 2 DCDA
87 A 25 PLB Geetha 60 30 2 1370 1
88 B 63 PLB Kalpana 270 34 1 2005 2
89 B 64 CHX Dhanalakshmi 150 34 4 1935 1
90 B 65 CHX Jayanthi 300 34 5 2275 2
91 B 66 CHX Venda 70 33 5 1340 1
92 B 67 PLB Mouli 90 32 6 1590 1
93 B 68 PLB Jansirani 200 32 6 1755 2
94 A 26 PLB Yasmin 240 30 3 1473 1
95 B 69 PLB Hemalatha 180 33 1 1790 1
96 A 27 CHX Karpagam 1 300 31 1 1310 1 MCMA
97 A 28 PLB Karpagam 2 300 31 1 1500 1 MCMA
98 B 70 CHX Ammu 1 270 34 5 1800 2 MCTA
99 B 71 CHX Ammu 2 270 34 5 1260 2 MCTA
100 B 72 CHX Ammu 3 270 34 5 1365 2 MCTA
101 B 73 PLB Ishwarya 120 33 5 1675 2
102 B 74 PLB Jayalakshmi 360 33 6 2540 1
103 B 75 PLB Suganya 120 34 3 2215 2
104 A 29 CHX Malliga 150 28 2 1240 2
105 A 30 PLB Karpagam 45 28 0 1030 1
106 B 76 PLB Thangamani 300 34 6 1760 1
107 B 77 CHX Manjula 180 33 3 2100 2
108 B 78 CHX Radha 120 34 3 1900 1
109 B 79 PLB Maheswari 30 34 5 1020 1
110 B 80 CHX Kalpana 180 34 0 1690 2
111 B 81 PLB Rajeswari 90 34 4 1940 1
112 B 82 CHX malleswari 150 33 0 1900 2
113 B 83 CHX Anjalai 70 32 2 1975 2
114 B 84 PLB Kalaiarasi 360 32 1 1535 1
115 B 85 PLB Bhavani 120 34 0 2235 1
116 B 86 PLB Kiruba 115 33 3 1750 2
117 B 87 CHX Sumithra 210 34 4 2240 1
118 B 88 PLB Vinodhini 120 34 3 2060 2
119 A 31 PLB Farhana 80 28 0 1245 1
120 B 89 CHX Meghala 80 33 0 1800 2
Vernix Matern Social st status cmater ANC visit mode Admin‐ adm del ANCS Preterm depPROM
1 22 12 2 2 4 1 9 1 1 1 2
1 27 7 1 1 3 1 12 1 1 1 2
1 22 24 3 3 4 4 7 1 3 2 1
1 27 13 2 2 3 1 11 1 1 1 2
1 21 11 2 2 4 1 4 1 1 1 2
2 19 16 3 2 2 1 10 1 3 3 2
1 20 17 3 2 5 4 8 1 3 1 2
2 23 14 2 1 1 1 6 1 1 1 2
2 21 13 2 1 4 2 96 4 1 3 2
2 26 25 3 2 3 4 6 1 3 3 2
1 21 23 3 2 3 4 144 4 3 1 2
1 26 19 3 1 4 1 312 4 2 2 1
1 20 12 2 1 3 1 21 2 2 3 2
1 24 10 1 1 3 1 216 4 3 1 2
1 25 22 3 1 3 4 72 3 1 3 2
2 24 17 3 2 3 2 18 2 1 1 2
2 24 17 3 2 4 2 11 1 1 1 2
1 23 9 1 2 3 1 0 1 1 1 2
2 28 18 3 2 4 1 9 1 1 1 2
2 21 11 2 1 5 1 29 3 2 2 1
2 20 8 1 1 1 1 336 4 1 1 2
1 32 13 2 1 5 4 360 4 1 3 2
1 27 9 1 1 2 1 6 1 1 1 2
1 28 12 2 1 2 4 7 3 3 3 2
1 38 13 2 2 5 4 144 4 3 3 2
1 24 12 2 2 4 1 72 3 3 2 1
2 26 15 2 2 4 1 9 1 1 1 2
2 29 13 2 1 3 3 96 4 1 1 2
1 29 7 1 1 3 4 13 2 2 1 2
1 21 16 3 1 4 4 9 1 1 3 2
1 20 15 2 2 6 4 8 1 1 3 2
1 18 11 2 1 2 4 2 1 1 3 2
1 22 14 2 2 3 1 10 1 1 1 2
2 26 22 3 3 5 3 288 4 3 3 2
2 26 22 3 3 5 3 288 4 3 3 2
2 27 11 2 1 4 1 5 1 1 1 2
2 27 11 2 1 4 1 5 1 1 1 2
1 27 11 2 1 4 1 26 2 2 2 1
1 31 11 2 1 3 2 6.5 1 1 2 1
2 21 21 3 3 4 4 48 4 2 3 2
1 23 14 2 2 4 1 0 1 1 1 2
1 21 13 2 1 2 1 6 1 1 2 1
1 21 13 2 1 2 1 6 1 1 2 1
1 32 19 3 2 4 4 48 4 3 3 2
2 24 17 3 2 4 1 8 1 1 1 2
1 27 18 3 1 4 4 10 1 1 1 2
1 27 18 3 1 4 4 10 1 1 1 2
2 22 10 2 1 3 4 72 4 3 3 2
1 24 8 1 1 1 1 10 1 1 3 2
1 28 22 3 1 6 4 18 2 3 3 2
2 20 18 3 1 4 1 7 1 1 3 2
2 24 19 3 1 4 1 3 1 1 1 2
2 22 25 3 2 4 4 3 1 3 3 2
2 22 25 3 2 4 4 3 1 3 3 2
2 30 12 2 1 2 4 7 1 1 3 2
1 20 11 2 1 3 4 7 1 1 3 2
2 23 15 2 3 5 1 5.5 1 2 1 2
2 23 15 2 3 5 1 5.5 1 2 1 2
1 40 14 2 1 6 4 7 1 3 3 2
1 40 14 2 1 6 4 7 1 3 3 2
2 23 12 2 1 5 4 6 1 1 3 2
1 28 13 2 1 5 4 6.5 1 2 3 2
1 20 12 2 1 4 2 3 1 1 1 2
1 20 12 2 1 4 2 3 1 1 1 2
1 21 18 3 1 6 1 0.5 1 1 1 2
1 20 19 2 3 4 1 8 1 2 1 2
1 20 19 2 3 4 1 8 1 2 1 2
1 24 13 2 1 3 1 9 1 2 2 1
1 29 13 2 2 4 4 19 2 2 3 2
1 21 9 1 1 2 1 18 2 1 1 2
1 29 9 1 1 3 4 672 4 1 3 2
1 24 22 3 2 4 2 7 1 1 1 2
1 24 22 3 2 4 2 7 1 1 1 2
2 21 18 2 2 4 1 16 2 2 1 2
2 25 13 2 3 5 2 2 1 1 1 2
1 22 12 2 2 6 1 96 4 1 1 2
1 29 11 2 2 3 1 48 4 3 2 1
2 37 9 1 3 5 4 9 3 3 2 1
1 18 8 1 3 3 4 4 1 1 3 2
1 19 19 3 1 4 1 72 4 3 1 2
1 22 12 2 1 4 1 48 4 2 3 2
1 27 16 2 2 4 1 36 3 3 2 2
2 28 13 2 1 4 4 144 4 1 1 2
1 25 14 2 1 3 1 0 1 1 1 2
2 22 21 3 2 5 4 9 1 1 1 2
2 22 21 3 2 5 4 9 1 1 1 2
1 22 16 3 1 2 1 6 1 2 2 1
1 23 16 3 2 5 4 312 4 3 2 1
1 20 18 3 1 3 4 8 1 2 2 2
2 27 15 2 1 5 2 19 2 2 3 2
1 28 14 2 2 2 4 552 4 3 3 2
1 18 18 2 2 6 4 7 1 2 3 2
1 20 12 2 1 2 1 27 3 3 1 2
1 22 16 3 1 3 1 9 1 1 1 2
1 23 15 2 2 4 1 168 4 3 1 2
1 35 12 2 1 4 2 3 1 3 3 2
1 35 12 2 1 4 2 3 1 3 3 2
1 27 10 1 1 4 4 10 3 3 1 2
1 27 10 1 1 4 4 10 3 3 1 2
1 27 10 1 1 4 4 10 3 3 1 2
2 24 21 3 3 5 4 1 1 1 3 2
1 30 18 3 3 4 4 1.5 1 1 3 2
2 23 13 2 2 5 4 2 1 1 1 2
1 27 7 1 1 1 1 9 1 1 3 2
1 28 12 2 1 2 1 12 1 3 1 2
2 29 16 3 2 4 4 4 1 1 3 2
2 20 12 2 2 4 1 18 2 1 2 1
2 30 14 2 1 3 1 13 1 1 2 1
1 25 13 2 1 5 3 120 4 3 3 2
1 29 14 2 2 3 1 0 1 3 1 2
2 23 12 2 2 4 4 96 4 3 1 2
1 20 12 2 1 4 1 60 3 2 1 2
2 28 13 2 1 5 4 48 3 2 3 2
2 21 15 2 2 5 1 1 1 1 1 2
2 26 19 3 3 4 4 24 2 1 1 2
1 22 17 3 2 5 1 48 3 2 1 2
1 27 15 2 2 5 4 24 2 1 3 2
1 22 18 3 2 6 4 6 1 3 3 2
1 24 21 3 3 3 4 0.75 1 1 3 2
1 24 14 2 1 4 1 48 3 3 1 2
ROM (hrs) Maternal sIAP  statusPVs No. PVs Lab Dura Apgar at 5 Emp antib Resus req Resus details
1 2 2 2 12 8 1 1 3
2 2 2 17 8 2 2 1
26 2 1 3 11 8 1 2 1
2 2 2 19 8 2 2 1
2 2 1 11 9 2 2 1
4 1 1 2 21 8 1 2 1
2 2 4 3 12 6 1 1 4
2 2 1 16 7 2 2 1
12 2 2 1 11 8 2 2 1
1 1 1 19 8 1 2 1
2 1 2 15 9 1 2 1
41 2 2 2 12 8 1 2 1
2 2 1 13 8 1 2 1
6 2 2 2 1 4 4 1 1 4
14 2 2 2 12 7 1 1 3
2 2 1 13 9 2 2 1
3 2 2 4 2 5 8 2 2 1
1 1 8 7 1 2 1
14 2 2 2 1 7 7 2 2 1
21 2 2 1 1 12 8 1 2 1
4 2 1 3 1 9 9 2 2 1
2 2 0.5 8 2 2 1
4 2 2 3 1 9 8 2 2 1
5 2 2 4 2 8 8 2 2 1
1 1 3 1 8 1 2 1
54 2 1 4 2 12 8 1 2 1
2 2 3 1 9 8 2 2 1
2 2 2 4 8 2 2 1
2 2 2 1 5 8 2 2 1
2 2 8 2 2 1
2 2 8 2 2 1
2 2 2 8 2 2 1
7 2 2 3 1 11 8 2 2 1
2 2 0 9 2 2 1
2 2 0 8 2 2 1
6 2 2 3 1 7 8 2 2 1
6 2 2 3 1 7 8 2 2 1
20 2 1 4 1 14 8 1 2 1
20 2 1 3 1 14 8 2 2 1
2 2 1 1 9 2 2 1
2 2 1 1 5 8 2 2 1
24 2 1 2 1 18 7 1 2 1
24 2 1 2 1 18 7 1 2 1
2 2 8 2 2 1
2 2 3 1 10 8 2 2 1
2 2 3 1 8 8 2 2 1
2 2 3 1 8 8 2 2 1
2 2 6 1 1 4
2 2 5 2 13 6 1 1 4
2 2 2 1 8 2 2 1
2 2 3 1 16 9 2 2 1
2 2 3 1 11 9 2 2 1
2 2 2 1 9 2 2 1
2 2 2 1 9 2 2 1
2 2 6 2 2 1
2 2 5 2 18 6 1 1 3
2 2 3 1 17 9 2 2 1
2 2 3 1 17 9 2 2 1
2 2 6 2 1 3
2 2 7 1 2 1
2 2 2 1 8 9 2 2 1
2 2 3 1 11 9 2 2 1
4 2 2 3 1 13 9 2 2 1
4 2 2 3 1 13 9 2 2 1
3 2 2 2 1 8 9 2 2 1
8 2 2 2 3 12 8 1 2 1
8 2 2 2 3 12 7 1 1 3
43 2 1 3 1 19 9 1 2 1
2 2 1 1 7 1 1 3
2 1 2 1 15 7 1 1 4
2 2 1 1 8 2 2 1
2 2 4 2 16 7 1 1 3
2 2 4 2 16 7 1 1 3
2 2 3 2 19 9 1 2 1
24 2 1 2 1 18 9 2 2 1
2 2 3 1 15 8 2 2 1
48 2 1 4 2 22 8 1 2 1
194 2 1 2 1 8 1 2 1
2 2 7 1 1 4
8 2 2 3 1 14 9 2 2 1
2 2 7 8 1 1 3
48 2 1 4 2 16 9 1 2 1
2 2 2 1 15 8 2 2 1
2 2 2 1 8 7 1 2 1
1 2 2 1 1 8 2 2 1
1 2 2 1 1 8 2 2 1
72 2 1 4 2 9 9 1 1 3
312 2 1 3 1 8 1 2 1
26 2 1 5 2 8 1 2 1
2 2 2 1 12 7 1 1 3
2 1 3 1 7 2 1 3
2 2 2 1 7 2 2 1
2 2 4 2 16 7 1 2 1
2 2 2 1 12 8 1 2 1
1 2 1 1 9 7 2 2 1
2 2 4 2 13 7 1 2 1
2 2 4 2 13 7 1 1 3
2 2 4 2 9 1 2 1
2 2 4 2 7 1 2 1
2 2 4 2 9 1 2 1
2 2 1 1 8 2 2 1
2 2 3 1 8 1 2 1
2 2 3 1 17 8 1 2 2
2 2 4 2 12 5 1 1 3
2 2 2 1 17 8 1 2 1
6 2 1 3 1 7 2 2 1
72 2 1 2 1 19 8 1 2 1
12 2 1 3 1 19 8 2 2 1
2 2 0 9 2 2 1
2 2 3 1 16 9 2 2 1
2 2 2 1 11 7 1 1 3
2 2 2 1 12 8 2 2 1
2 2 2 1 8 2 2 1
2 2 2 1 11 6 2 1 3
2 2 3 1 9 2 2 1
2 2 1 1 19 9 2 2 1
2 2 9 2 2 1
2 2 8 2 2 1
2 2 1 1 8 2 2 1
2 2 1 1 18 8 2 2 1
support Formcirc support  Mech ve Surfactant  IV line duration Picc lineduration Umblical linDuration
2 1 2 2 1 7 2 2
3 1 2 2 2 2 2
3 1 2 2 1 5 2 2
3 1 2 2 1 15 2 2
3 1 2 2 1 1 2 2
3 1 1 2 1 19 2 2
4 1 1 1 1 17 1 5 1 3
3 1 2 2 2 2 2
3 1 2 2 2 2 2
2 1 1 1 1 23 1 8 1 5
3 1 1 2 1 17 1 5 2
3 1 2 2 1 5 2 2
3 1 1 2 1 14 1 8 2
2 1 2 2 1 17 1 6 2
3 1 1 1 2 6 2 1 3
2 1 2 2 1 16 2 2
3 1 2 2 1 17 2 2
2 1 2 2 1 3 2 2
3 1 2 2 1 4 2 2
3 1 2 2 1 3 2 2
3 2 2 2 1 10 2 2
3 1 2 2 1 5 2 2
3 1 2 2 2 2 2
2 2 2 2 1 13 1 7 2
3 2 1 2 1 10 1 8 2
3 1 2 2 1 3 2 2
1 1 2 2 2 2 2
3 1 2 2 2 2 2
3 1 1 2 1 20 1 8 2
3 1 2 2 2 2 2
2 2 2 1 1 14 2 2
2 2 1 2 2 21 2 5 2
3 1 2 2 2 2 2
3 1 2 2 2 2 2
3 1 2 2 2 2 2
3 1 2 2 2 2 2
3 1 2 2 2 2 2
3 1 2 2 1 5 2 2
3 1 2 2 2 2 2
2 2 1 1 2 5 2 2
3 1 2 2 2 2 2
3 2 1 2 1 24 1 8 2
3 2 1 2 1 7 1 7 2
3 1 2 2 2 2 2
2 1 2 2 1 3 2 2
3 1 2 2 2 2 2
3 1 2 2 2 2 2
4 2 1 1 1 7 1 3 2
4 2 1 1 1 4 1 3 2
3 1 2 2 2 2 2
3 1 2 2 1 6 2 2
3 1 2 2 2 2 2
3 1 2 2 1 4 2 2
3 1 2 2 2 2 2
3 1 1 2 1 20 2 2
2 2 1 1 2 21 1 5 2
3 1 2 2 1 3 2 2
3 1 2 2 1 3 2 2
4 2 1 1 1 5 1 5 2
4 2 1 1 1 18 2 2
3 1 2 2 2 2 2
3 1 1 1 1 17 2 2
3 1 2 2 1 12 1 10 2
2 2 1 2 1 21 1 6 2
3 1 2 2 2 2 2
3 1 2 2 1 5 2 2
2 2 1 2 1 25 1 8 2
3 1 2 2 1 7 2 2
2 1 1 2 1 5 2 2
4 2 1 1 1 3
3 1 2 2 2 2 2
2 2 1 1 1 2 2 2
2 2 1 1 1 2 2 2
3 1 1 1 2 2 2
2 1 1 2 1 15 2 2
3 1 2 2 2 2
3 1 2 2 1 3 2 2
3 1 2 2 1 14 2 2
4 1 1 1 1 3 2 2
3 1 2 2 2 2 2
2 1 2 2 1 11 1 5 2
3 1 2 2 1 6 2 2
2 1 2 2 2 2 2
2 1 2 2 1 7 2 2
4 1 1 2 1 5 1 5 2
4 1 1 2 2 2 2
3 1 2 2 1 5 2 2
3 1 2 1 1 7 2 2
3 1 2 2 2 2 2
2 1 2 2 1 3 2 2
2 1 1 1 1 9 2 2
3 1 1 1 1 7 2 2
2 2 1 1 1 5 2 2
2 2 1 1 1 3 2 2
3 1 2 2 1 5 2 2
2 1 1 2 1 5 2 1 4
2 1 2 2 1 7 2 2
3 1 2 2 2 2 2
3 1 2 2 2 2 2
3 1 2 2 2 2 2
3 1 2 2 1 2 2
2 2 1 1 1 21 2 1 6
4 2 1 1 1 5 2 2
2 2 2 2 1 9 2 2
3 1 1 1 1 13 1 8 1 4
3 1 2 2 2 2 2
3 1 2 2 1 5 2 2
3 1 2 2 2 2 2
3 1 2 2 1 17 1 6 1 4
3 1 2 2 2 2 2
2 2 1 1 1 15 1 9 2
3 1 2 2 2 2 2
2 1 1 1 1 14 2 2
2 1 2 2 1 8 2 2
3 1 2 2 2 2 2
2 1 2 2 2 2 2
3 1 2 2 1 16 1 8 2
3 1 2 2 2 2 2
2 2 2 1 1 4 2 2
3 1 2 2 2 2 2
 Clinical dete Sep Screen Blood culture culture organisSepsis + Sep/culturemeningitis culture
1 2 2 7 1 3
2 1 3
1 2 2 7 1 3
1 1 1 4 2 1 2 2
2 1 3
1 1 1 3 2 1 1 2
1 2 2 7 1 3 2
2 1 3
2 1 3
1 1 2 7 2 2 2 2
1 1 1 4 2 1 2 2
2 1 3
1 2 2 7 1 3
1 1 2 7 2 2
2 1 3
1 1 1 5 2 1 2 2
2 1 3
2 1 3
1 2 2 7 1 3
2 1 3
1 1 2 7 2 2 2 2
1 2 2 7 1 3
2 1 3
1 1 2 7 2 2
1 1 1 4 2 1 2 2
2 1 3
2 1 3
2 1 3
1 1 1 3 2 1 2 2
2 1 3
1 1 2 7 2 2
1 1 1 4 2 1 1 2
2 1 3
2 1 3
2 1 3
2 1 3
2 1 3
1 1 2 7 2 2
2 1 3
1 2 2 7 1 3
2 1 3
1 1 1 4 2 1 2 2
1 1 1 4 2 1 2 2
2 1 3
1 2 2 7 1 3
2 1 3
2 1 3
1 1 1 2 2 1 2 2
1 1 2 7 2 2 2 2
2 1 3
1 2 2 7 1 3
2 1 3
2 1 3
2 1 3
1 1 2 7 2 2
1 1 1 3 2 1 2 2
2 1 3
2 1 3
1 1 2 7 2 2
2 2 2 7 1 3
2 1 3
1 1 2 7 2 2
1 1 2 7 2 2
1 1 1 3 2 1 2 2
2 1 3
2 1 3
1 1 2 7 2 2 2 2
1 2 2 7 1 3 2 2
1 2 2 7 1 3
1 1 2 7 2 2
2 1 3
1 2 2 7 1 3
1 2 2 7 1 3
2 1 3
1 1 2 7 2 2
2 1 3
2 1 3
1 1 1 2 2 1 2 2
1 2 2 7 1 3
2 1 3
1 1 2 7 2 2 2 2
2 1 3
2 1 3
1 1 2 7 2 2 2 2
1 2 2 7 1 3
2 1 3
1 2 2 7 1 3
1 1 2 7 2 2
2 1 3
2 1 3
1 1 2 7 2 2
2 1 3
2 1 3
1 2 2 7 1 3
1 2 2 7 1 3
2 1 3
1 1 2 7 2 2
2 1 3
2 1 3
2 1 3
2 1 3
1 1 1 3 2 1 2 2
1 1 2 7 2 2 2 2
2 1 3
1 2 1 1 2 1 2 2
2 1 3
2 1 3
2 1 3
1 1 1 3 2 1 2 2
2 1 3
1 1 1 1 2 1 2 2
2 1 3
1 1 1 3 2 1 2 2
1 1 2 7 2 2 2 2
2 1 3
2 1 3
1 1 2 7 2 2 2 2
2 1 3
1 2 2 7 1 3
2 1 3
Discharge sAlive ‐ D 30D 30 statusHosp outcoHosp stay ‐ Hosp stay ‐ Rpt adm Reason DOL
1 1 1 1 12 2
1 1 1 1 8 2
1 1 1 1 9 2
1 1 1 1 25 2
1 1 1 1 11 2
2 1 3 1 40 2
1 1 1 1 32 2
1 1 1 1 10 2
1 1 1 1 9 2
2 1 4 2
1 1 1 1 22 2
1 1 1 1 17 2
1 1 1 1 23 2
2 1 4 2
1 1 1 1 19 2
2 1 4 1 35 2
2 1 4 1 35 2
1 1 12
2 2 2 2 7 2
1 1 1 1 10 1 1 17
1 1 1 1 12 2
1 1 1 1 8 2
1 1 1 1 7 2
2 1 4 1 32 2
2 2 2 2 10 2
1 1 1 1 11 2
1 1 1 1 7 2
1 1 1 1 9 1 1 14
2 1 4 1 35 2
1 1 1 1 21 2
1 1 1 1 22 2
2 1 3 1 44 2
1 1 1 1 9 2
1 1 1 1 9 2
1 1 1 1 9 2
1 1 1 1 9 2
1 1 1 1 9 2
1 1 1 1 9 2
1 1 1 1 9 2
1 1 1 1 21 2
1 1 1 1 19 2
2 1 4 2
2 2 2 2 7 2
1 1 1 1 8 2
1 1 1 1 14 2
1 1 1 1 14 2
1 1 1 1 14 2
2 2 2 2 7 2
2 2 2 2 4 2
1 1 1 1 10 2
1 1 1 1 10 2
1 1 1 1 10 2
1 1 1 1 13 2
1 1 1 1 13 2
1 1 1 1 21 2
2 2 2 2 22 2
1 1 1 1 17 2
1 1 1 1 17 2
2 2 2 2 5 2
2 1 4 1 37 2
1 1 1 1 22 2
2 2 2 2 21 2
2 1 4 2
2 2 2 2 21 2
1 1 1 1 15 2
1 1 1 1 27 2
2 1 3 1 27 1 1 29
2 1 3 1 14 1 1 27
1 1 1 1 27 2
2 2 2 2 4 2
1 1 1 1 21 2
2 2 2 2 1 2
2 2 2 2 2 2
1 1 1 1 10 2
1 1 1 1 10 2
1 1 1 1 24 2
1 1 1 1 9 2
1 1 1 1 17 2
2 2 2 2 3 2
1 1 1 1 8 2
2 1 4 1 35 2
2 1 4 1 37 2
1 1 1 1 11 2
1 1 1 1 17 2
1 1 1 1 12 2
1 1 1 1 12 2
1 1 1 1 26 2
1 1 1 1 9 2
1 1 1 1 10 2
1 1 1 1 12 2
1 1 1 1 18 2
1 1 1 1 25 2
1 1 12
2 2 2 2 3 2
2 1 3 1 17 1 1 27
1 1 1 1 26 2
1 1 1 1 26 2
1 1 1 1 21 2
1 1 1 1 21 2
1 1 1 1 21 2
1 1 1 1 12 2
2 1 3 2
1 1 1 1 19 2
1 1 1 1 22 2
1 1 1 1 28 2
1 1 1 1 25 2
1 1 1 1 10 2
1 1 1 1 10 2
2 2 2 2 23 2
1 1 1 1 14 2
2 1 3 1 27 1 2 30
1 1 1 1 11 2
1 1 1 1 25 2
1 1 1 1 28 2
1 1 1 1 11 2
1 1 1 1 11 2
1 1 1 1 17 2
1 1 1 1 13 2
2 2 2 2 4 2
1 1 1 1 12 2
Abs days Antibiotic sSepsis + Sep epi in HoW 1TI W1T2 W1T3
5 1 1 36.8 1 36.2 1 36.5 1
2 1 36.5 1 36 1 36.4 1
5 1 1 36.8 1 36.3 1 36.5 1
14 1 2 1 36.8 1 36 1 36.2 1
2 1 36.5 1 35.8 2 36.4 1
27 1 2 3 36.5 1 36.1 1 36 1
10 1 1 1 36.9 1 34.2 3 36.3 1
2 1 36.8 1 36.2 1 36.5 1
2 1 36.5 1 36.3 2 36.5 1
18 1 2 2 36.5 1 35.1 3 36.5 1
17 1 2 1 36.5 1 35.1 3 36.4 1
5 1 1 36.5 1 35.8 2 36.5 1
3 1 1 36.5 1 35.1 3 36.3 1
17 1 2 2 36.5 1 35.1 3 36.5 1
2 1 36.5 1 35 3 36.5 1
14 1 2 1 36.5 1 35.1 3 36.5 1
17 1 1 1 36.5 1 35.1 3 36.5 1
3 1 1 36.5 1 36.5 1 36.5 1
4 1 1 1 36.4 1 35.8 2 35.8 2
3 1 1 1 36.5 1 36.4 1 36.5 1
10 1 2 1 36.5 1 36.1 1 36.5 1
5 1 1 36.5 1 36.4 1 36.5 1
2 1 36.5 1 36.1 1 36.5 1
10 1 2 1 36.5 1 35.4 3 36.4 1
10 1 2 1 36.8 1 32.1 3 36.5 1
3 1 1 36.5 1 36.5 1 36.5 1
2 1 36.5 1 36.5 1 36.5 1
2 1 36.5 1 36.4 1 36.5 1
18 1 2 1 36.5 1 34.9 3 36.5 1
2 1 36.5 1 35.4 3 36.5 1
14 1 2 1 36.5 1 36 1 36.5 1
21 1 2 3 36.5 1 35.1 3 36.5 1
2 1 36.5 1 36.4 1 36.5 1
2 1 36.5 1 36.2 1 36.5 1
2 1 36.5 1 36.2 1 36.5 1
2 1 36.5 1 36.5 1 36.5 1
2 1 36.5 1 36.5 1 36.5 1
7 1 2 1 36.5 1 36.5 1 36.5 1
2 1 36.5 1 36.2 1 36.3 1
3 1 1 36.5 1 36 1 36.5 1
2 1 36.5 1 36.5 1 36.5 1
24 1 2 3 36.5 1 34.1 3 36.5 1
7 1 2 1 36.5 1 35.4 3 36.5 1
2 1 36.5 1 36.2 1 36.5 1
3 1 1 36.5 1 36.5 1 36.5 1
2 1 36.5 1 36.5 1 36.5 1
2 1 36.5 1 36.5 1 36.5 1
7 1 2 1 36.5 1 36 1 36.5 1
4 1 2 1 36.5 1 36 1 36.5 1
2 1 36.5 1 36.5 1 36.5 1
3 1 1 36.5 1 36.5 1 36.5 1
2 1 36.5 1 36.5 1 36.5 1
2 1 36.5 1 36 1 36.5 1
2 1 36.5 1 36 1 36.5 1
20 1 2 2 36.5 1 36.4 1 36.5 1
21 1 2 2 36.5 1 35.8 2 36.5 1
2 1 36.5 1 36.5 1 36.5 1
2 1 36.5 1 36.5 1 36.5 1
5 1 2 1 36.5 1 35.8 2 36.5 1
14 1 1 2 36.5 1 35.8 2 36.5 1
10 1 1 1 36.5 1 36.4 1 36.5 1
16 1 2 2 36.5 1 35.4 1 36.5 1
10 1 2 1 36.5 1 35.2 3 36.5 1
21 1 2 2 36.5 1 34.1 3 36.5 1
2 1 36.1 1 36.1 1 36.5 1
5 1 1 36.5 1 35.1 3 36.5 1
25 1 2 2 36.5 1 35.1 3 36.5 1
18 1 1 2 36.5 1 36.2 1 36.5 1
3 1 1 36.5 1 35.2 3 36.5 1
3 1 2 1 36.5 1 35.2 3 36.5 1
2 1 36.5 1 36.4 1 36.5 1
2 1 1 36.5 1 35.2 3 36.5 1
2 1 1 36.5 1 35.2 3 36.5 1
2 1 36.5 1 36.5 1 36.5 1
7 1 2 1 36.5 1 36.2 1 36.5 1
10 1 1 1 36.5 1 36.4 1 36.5 1
3 1 1 36.5 1 36.5 1 36.5 1
14 1 2 1 36.5 1 36.5 1 36.5 1
3 1 1 36.5 1 35.1 3 36.5 1
2 1 36.5 1 36.4 1 36.5 1
10 1 2 1 36.5 1 36.5 1 36.5 1
5 1 1 36.4 1 35.1 3 36.5 1
3 1 1 36.5 1 36.1 1 36.5 1
7 1 2 1 36.5 1 36.4 1 36.5 1
3 1 1 36.5 1 35.4 3 36.5 1
2 1 36.5 1 35.1 3 36.5 1
5 1 1 36.5 1 35.8 2 36.5 1
7 1 2 1 36.5 1 36.3 1 36.5 1
3 1 1 36.5 1 35.7 1 36.5 1
3 1 1 36.5 1 36.2 1 36.5 1
7 1 2 1 36.5 1 35.8 2 36.5 1
3 1 1 2 36.5 1 36.4 1 36.5 1
5 1 1 36.1 1 36.5 1 36.5 1
3 1 1 36.5 1 36.2 1 36.5 1
3 1 1 1 36.4 1 36.4 1 36.5 1
5 1 1 36.5 1 35.1 3 36.5 1
7 1 2 1 36.5 1 35.8 2 36.5 1
2 1 36.5 1 35.8 2 36.5 1
7 1 1 1 36.5 1 35.8 2 36.5 1
2 1 36.5 1 35.8 2 36.5 1
2 1 36.5 1 35.8 2 36.5 1
18 1 2 3 36.5 1 36.5 1 36.5 1
14 1 2 2 36.5 1 35.8 3 36.5 1
5 1 1 36.5 1 35.4 3 36.5 1
14 1 2 2 36.5 1 35.8 2 36.5 1
2 1 36.5 1 36.5 1 36.5 1
5 1 1 36.5 1 35.8 2 36.5 1
2 1 36.5 1 36.5 1 36.5 1
16 1 2 2 36.5 1 35.4 3 36.5 1
2 1 36.5 1 36.5 1 36.5 1
14 1 2 1 36.5 1 36.1 1 36.5 1
2 1 36.5 1 36.5 1 36.5 1
14 1 2 1 36.5 1 35.4 3 36.5 1
7 1 2 1 36.5 1 35.4 3 36.5 1
2 1 36.5 1 35.4 3 36.5 1
2 1 36.5 1 35.2 3 36.5 1
14 1 2 1 36.5 1 36.1 1 36.5 1
2 1 36.5 1 35.9 2 36.5 1
2 1 1 36.5 1 35.2 3 36.5 1
2 1 36.5 1 36.5 1 36.5 1
W 2T1 W2T2 W2T3 W3T1 W3T2
36.5 1 36.3 1 36.5 1 36.4 1 36.5 1
36.5 1 36.1 1 36.5 1 36.5 1 36.1 1
36.4 1 36.2 1 36.5 1 36.5 1 36.1 2
36.5 1 36.3 1 36.5 1 36.4 1 36 2
36.4 1 35.9 2 36 1 36.5 1 36.2 2
36.8 1 36.3 1 36.5 1 36.1 1 35.2 3
36.5 1 35.1 3 36.5 1 36.5 1 35.5 3
35.4 1 35.2 3 35.2 3 35.9 1 35.4 3
36.5 1 36.1 1 36.4 1 36.5 1 36.4 1
36.5 1 34.2 3 36.5 1 36.5 1 35.8 2
36.5 1 36.4 1 36.5 1 36.5 1 35.3 3
36.5 1 35.4 3 36.4 1 36.5 1 35.2 3
36.5 1 35.6 2 36.5 1 36.5 1 35.8 2
36.4 1 36.5 1 35.4 3 36.5 1 35.6 2
36.5 1 34.9 3 36.5 1 36.5 1 34.7 3
36.5 1 35.2 3 36.5 1 36.5 1 36 1
36.5 1 35 3 36.5 1 36.5 1 35.8 2
36.5 1 36.5 1 36.5 1 36.5 1 36.5 1
36.5 1 36.2 1 36.5 1 36.8 1 36.4 1
36.5 1 36.5 1 36.5 1 36.5 1 36.5 1
36.5 1 34.2 3 36.5 1 36.5 1 35.1 3
36.5 1 36.3 1 36.5 1 36.5 1 36.5 1
36.5 36.4 1 36.5 1 36.5 1 36.3 1
36.5 1 35.2 3 36.5 1 36.5 1 35.1 3
36.5 1 34 3 36.4 1 36.4 1 35 3
36.5 1 36.5 1 36.5 1 36.5 1 36.5 1
36.5 1 36.5 1 36.5 1 36.5 1 36.5 1
36.5 1 35.7 2 35.4 2 36.5 1 35.7 2
36.5 1 35.4 2 36.5 1 36.5 1 36.3 1
36.5 1 35.3 3 36.5 1 36.5 1 36.1 1
36.4 1 36.2 1 36.5 1 36.5 1 36 1
36.5 1 35.8 3 36.2 1 36.5 1 36.2 1
36.5 1 36.2 1 36.5 1 36.4 1 36.5 1
34.5 3 35 3 35 3 35 3 35 3
34.5 3 35 3 35 3 35 3 35 3
36.2 1 36.2 1 36.2 1 35.9 2 35.2 2
36.2 1 36.2 1 36.2 1 35.9 2 35.2 2
36.5 1 36.5 1 36.5 1 36.5 1 36.5 1
36.5 1 36.5 1 36.5 1 36.5 1 36.5 1
36.5 1 35.8 2 36 1 36.5 1 36.5 1
36.5 1 36.5 1 36.5 1 36.5 1 36.5 1
36.5 1 35.6 2 36.5 1 36.5 1 35.3 3
36 1 35.2 3 35.9 2 36.2 1 35.2 3
36.5 1 35.5 2 36.5 1 36.5 1 35.2 3
36.5 1 36.5 1 36.5 1 36.5 1 36.5 1
36.5 1 36.5 1 36.5 1 35.4 3 35.8 2
36.5 1 35.1 3 36.5 1 35.8 2 35.4 3
36.5 1 36.2 1 36.5 1 36.5 1 36.3 1
36.5 1 36.5 1 36.1 1
35.6 2 35 3 35 3 35.1 3 35 3
36.5 1 36.5 1 36.5 1 36.5 1 36.5 1
36.5 1 36.5 1 36.5 1 35.8 2 35.4 3
36.5 1 36.1 1 36.5 1 36.5 1 36.3 1
36.5 1 36.1 1 36.5 1 36.5 1 36.3 1
36.5 1 36.3 1 36.5 1 36.5 1 36.5 1
36.5 1 35.2 3 35.6 2 36.5 1 35.9 2
36.5 1 36.5 1 36.5 1 36.5 1 36.5 1
36.5 1 36.5 1 36.5 1 36.5 1 36.5 1
36.5 1 36.1 1 36.5 1 36.5 1 36 1
36.5 1 36.1 1 36.5 1 36.5 1 36 1
36.5 1 36.5 1 36.5 1 36.5 1 36.5 1
36.5 1 35.9 2 36.5 1 36.5 1 36.2 1
36.5 1 35.4 3 36.5 1 36.5 1 36.2 1
36.5 1 35.4 3 36.5 1 36.5 1 36 1
36.5 1 36.2 1 36.5 1 36.5 1 35.4 1
36.5 1 35.4 3 36.5 1 36.5 1 36.2 1
36.5 1 35.1 3 36.5 1 36.5 1 36 1
36.5 1 36 1 36.5 1 36.5 1 36.1 1
36.5 1 35.4 3 36.5 1 36.5 1 36.1 1
36.5 1 35.1 3 36.5 1
36.5 1 36.2 1 36.5 1 36.5 1 36.4 1
36.5 1 36.5 1 36.5 1 36.5 1 36.5 1
36.5 1 36.4 1 36.5 1 36 1 36.3 1
36.5 1 36.2 1 36.5 1 36.5 1 36.1 1
36.5 1 36.5 1 36.5 1 36.5 1 36.5 1
36.5 1 36.5 1 36.5 1 36.5 1 36.5 1
36.5 1 35.3 3 36.5 1
36.5 1 36.2 1 36.5 1 36.5 1 36.5 1
36.5 1 35.9 2 36.3 1 36.5 1 36.4 1
36.5 1 35.6 2 36.5 1 36.5 1 35.6 2
36.5 1 36 1 36.5 1 36.1 1 35.2 3
36.5 1 36.2 1 36.5 1 36.5 1 36.4 1
36.5 1 36.2 1 36.5 1 36.5 1 36.4 1
36.2 1 36.5 1 36.5 1 36.5 1 36.5 1
36.5 1 36.2 1 36.5 1 36.3 1 36.5 1
36.5 1 36.4 1 36.5 1 36.5 1 36.4 1
36.5 1 36.2 1 36.5 1 36.5 1 36 1
36.5 1 36.1 1 36.5 36.5 1 36.4 1
36.5 1 35.4 3 36.4 1 36.5 1 36.2 1
36.2 1 36 1 36.5 1 36.4 1 36.1 1
36.5 1 36.3 1 36.5 1 36.5 1 36.2 1
36.5 1 35.2 3 36.5 1
36.5 1 36.5 1 36.5 1 36.5 1 36.5 1
36.5 1 35.4 3 36.5 1 36.6 1 35.8 2
35.8 2 36.5 1 36.5 1 36.6 1 36.2 1
36.5 1 36.2 1 36.5 1 36.5 1 36.5 1
36.5 1 36.2 1 36.5 1 36.5 1 36.5 1
36.5 1 36.2 1 36.5 1 36.5 1 36.5 1
36.5 1 36.2 1 36.5 1 36.5 1 36.5 1
36.5 1 36.5 1 36.5 1 36.5 1 36.5 1
36.5 1 36.2 1 36.5 1 36.5 1 36.5 1
36.5 1 36.1 1 36.5 1 36.5 1 36.4 1
36.5 1 35.4 3 36.5 1 36.5 1 35.1 3
36.5 1 36.5 1 36.5 1 36.5 1 36.5 1
36.5 1 36.2 1 36.5 1 36.5 1 36.5 1
36.5 1 36.5 1 36.5 1 36.5 1 36.5 1
36.5 1 36.5 1 35.6 2 36.5 1 35.4 3
36.5 1 36.5 1 36.5 1 36.5 1 36.5 1
36.5 1 36.5 1 36.5 1 36.5 1 36.5 1
36.5 1 35.9 2 36.5 1 36.5 1 36 1
36.5 1 36.2 1 36.5 1 36.5 1 36.3 1
36.5 1 35.1 3 36.5 1 36.5 1 35.6 2
36.5 1 35.9 2 36.5 1 36.5 1 36.5 1
36.5 1 36.5 1 36.5 1 36.5 1 36.5 1
36.5 1 36.2 1 36.5 1 36.5 1 36.5 1
36.5 1 36.5 1 36.5 1 36.5 1 36.5 1
36.5 1 36.1 2 36.5 1
36.5 1 36.5 1 36.5 1 36.5 1 36.5 1
W3T3 AX‐ cc‐B Axil ‐ B AX‐ cc‐24 Axil‐24 AX‐ cc‐48 Axil ‐ 48
36.5 1 0 7 1000 1 0 7
36.3 1 100000 1 100000 1 0 7
36.5 1 100000 1 100 1 0 7
36.5 1 100000 1 100000 2 100 2
36.5 1 100000 1 0 7 0 7
36.4 1 10000 1 10000 2 0 7
36.5 1 0 7 0 7 0 7
36.2 1 0 7 100 2 0 7
36.5 1 100 1 0 7 100000 1
36.5 1 1000 2 1000 1 100000 1
36.5 1 1000 2 100000 2 100000 1
36.5 1 1000 1 10000 2 100 1
36.5 1 0 7 100 2 1000 1
36.5 1 10000 1 100 1 100 1
36.5 1 1000 1 1000 2 100 1
36.5 1 10000 1 1000 1 1000 2
36.3 1 100 1 10000 1 10000 1
36.5 1 100 1 1000 1 0 7
36.5 1 0 7 0 7 100 1
36.5 1 100 1 0 7 100 2
36.5 1 1000 2 100000 2 10000 2
36.5 1 0 7 100 1 100000 1
36.5 1 0 7 0 7 0 7
36.5 1 0 7 100000 1 10000 1
36.5 1 100 2 10000 2 100000 2
36.5 1 100 1 0 7 1000 1
36.5 1 100 1 100 1 100 2
35.4 2 100 1 10000 1 100000 2
36.2 1 0 7 0 7 100 1
36.4 1 0 7 1000 2
36.5 1 0 7 100000 1
36.5 1 0 7 100000 1
36.5 1 0 7 100 2
35 3 0 7 0 7 100000 2
35 3 10000 2 100000 2 0 7
35.9 2 100 1 100000 1 100000 2
35.9 2 100 1 100000 2 100000 1
36.5 1 100000 2 100000 2 0 7
36.5 1 100 1 0 7 100000 2
36.5 1 100 2 10000 2 100 2
36.5 1 10000 1 100 1 0 7
36.5 1 0 7 0 7 100000 2
36.3 1 0 7 0 7 100000 2
35.4 3 100 1 10000 1 100000 1
36.5 1 0 7 100 1 0 7
36 1 0 7 100000 1 100 1
36.5 1 0 7 100000 1 100000 1
36.5 1 1000 1 0 7 1000 1
100 1 100 2 10000 2
35 3 0 7 100 2 0 7
36.5 1 0 7 100 1 0 7
35.4 1 0 7 1000 1 1000 2
36.5 1 0 7 0 7
36.5 1 100 2 100000 1
36.3 1 0 7 0 7 100 2
36.5 1 1000 2 0 7 10000 1
36.5 1 10000 1 0 7 100 2
36.5 1 100 1 0 7 0 7
36.5 1 0 7 100 2 10000 1
36.5 1 100 1 0 7 0 7
36.5 1 100 1 100 1 10000 2
36.5 1 10000 1 1000 2 100 2
36.5 1 100 2 0 7 0 7
36.5 1 10000 2 1000 2 100 2
36.2 1 100 1 100000 2 1000 2
36.5 1 0 7 0 7 0 7
36.5 1 0 7 0 7 100 2
36.5 1 10000 1 1000 2 10000 2
36.5 1 10000 1 100000 2 0 7
100 2 100000 2 10000 2
36.5 1 1000 2 100 2 0 7
10000 1
1000 2 1000 2
36.5 1 10000 2 10000 2 0 7
36.5 1 0 7 10000 2 1000 2
36.5 1 0 7 0 7 100 2
36.5 1 0 7 10000 2 10000 2
36.5 1 0 7 10000 2 10000 2
0 7 0 7 0 7
36.5 1 100000 2
36.5 1 0 7 0 7 0 7
36.5 1 100000 1 1000 2 100 2
36.5 1 100000 1 100000 2 100000 2
36.5 1 100000 1 100000 2 100000 2
36.5 1 0 7 1000 1 1000 2
36.5 1 0 7 10000 2 100 1
36.5 1 0 7 100000 2 100000 2
36.5 1 0 7 100 2 10000 1
36.5 1 100 2 100 2 0 7
36.5 1 0 7 0 7 0 7
36.5 1 0 7 0 7 10000 2
36.3 1 100000 2 1000 2
36.5 1 10000 2 10000 2 1000 2
10000 2 10000 2 100000 2
36.5 1 100000 2 10000 2 1000 2
36.5 1 0 7 10000 2 0 7
36.5 1 0 7 0 7 1000 2
36.5 1 100 1 0 7 0 7
36.5 1 1000 1 1000 1 10000 1
36.5 1 0 7 100 1 100 1
36.5 1 0 7 10000 2 0 7
36.5 1 0 7 100 2 10000 2
36.5 1 1000 1 0 7 100 2
36.5 1 100 1 1000 1 100 2
36.5 1 0 7 100 2 10000 2
36.5 1 0 7 1000 2 100000 2
36.5 1 100 2 0 7 10000 1
36.5 1 0 7 10000 2 10000 2
36.5 1 0 7 1000 2 10000 2
36.5 1 0 7 10000 2 100000 2
36.5 1 1000 2 0 7 10000 2
36.5 1 100 2 10000 2 0 7
36.5 1 0 7 0 7 100 2
36.5 1 0 7 10000 2 10000 2
36.5 1 0 7 1000 1 1000 1
36.5 1 100000 2 100000 1 10000 2
36.5 1 0 7 10000 2 0 7
36.5 1 0 7 1000 2 0 7
0 7 0 7 0 7
36.5 1 100000 2 0 7 1000 2
AX‐ cc‐ D7 Axil ‐  D7 GR‐cc‐ B Groin ‐ B GR‐cc‐ 24 Groin ‐ 24 GR‐cc‐ 48 Groin‐ 48
0 7 0 7 0 7 100 1
0 7 100000 1 10000 2 0 7
100000 2 100000 2 1000 2 100000 1
100 2 100000 1 10000 1 0 7
1000 2 100000 1 100 2 0 7
100 2 100000 2 100000 2 100 2
100000 2 0 7 0 7 0 7
100 2 0 7 1000 1 100 1
1000 1 0 7 0 7 10000 2
100000 1 1000 1 1000 1 10000 1
100000 1 100 2 100000 1 100000 2
100000 1 100 1 10000 1 100000 1
10000 1 0 7 100 2 100000 2
1000 1 1000 1 100 1 0 7
0 7 1000 1 0 7 100000 2
100 1 1000 1 1000 1 10000 1
1000 1 100 1 10000 1 1000 1
0 7 100 1 1000 1 0 7
0 7 0 7 100 1
100000 2 0 7 0 7 100 2
1000 2 100 2 100000 2 10000 2
100000 1 0 7 100 1 100000 1
100000 1 0 7 0 7 0 7
10000 1 0 7 100000 1 10000 1
100000 2 100 2 1000 2 100000 1
0 7 100 1 0 7 1000 2
100000 1 100 1 100 1 100 1
100000 2 0 7 10000 1 100000 2
10000 1 0 7 0 7 100 1
100000 2 0 7 10000 1
100000 1 0 7 100000 1
100000 1 0 7 1000 1
0 7 0 7 1000 1
0 7 0 7 0 7 100000 2
1000 1 10000 2 0 7 100000 2
0 7 0 7 100000 2 100000 2
0 7 0 7 100000 2 100000 2
10000 2 100000 1 100000 2 0 7
0 7 0 7 0 7 100 2
100000 2 10000 2 1000 2 1000 2
0 7 100 1 100000 2 1000 2
0 7 0 7 0 7 10000 2
100000 2 0 7 0 7 100000 2
100000 1 10000 1 10000 1 100000 1
100000 1 0 7 0 7 0 7
100000 1 0 7 100000 2 100000 1
100000 1 0 7 10000 2 100000 1
0 7 10000 1 0 7 0 7
0 7 100 2 10000 2
100000 2 0 7 100 2 0 7
0 7 100 1 100 1 100 2
0 7 100 1 0 7 10000 2
0 7 100000 1 1000 2
1000 2 0 7 0 7
1000 2 0 7 0 7 100 2
10000 1 0 7 1000 1 100000 7
0 7 100 1 0 7 100 2
0 7 1000 1 0 7 0 7
0 7 100000 2 10000 1
0 7 0 7 0 7 0 7
0 7 100 1 100 1 10000 2
1000 1 10000 1 1000 2 10000 2
0 7 100000 1 0 7 0 7
100 1 100 1 1000 2 100000 2
100000 2 10000 1 100000 2 10000 1
0 7 0 7 1000 2 0 7
1000 2 0 7 1000 2 1000 2
0 7 1000 1 10000 2 10000 2
0 7 10000 1 10000 2 0 7
100 2 100000 2 100000 2
0 7 10000 2 10000 2 0 7
0 7
0 7 100 1
0 7 1000 2 100000 2 0 7
100 1 0 7 100000 2 100000 2
100000 1 0 7 0 7 10000 2
1000 1 0 7 10000 2 10000 2
1000 1 0 7 0 7 0 7
0 7 0 7 0 7
100 2 10000 2
0 7 0 7 0 7 100000 2
100 2 1000 2 10000 2 100 2
100000 2 100000 2 10000 2 100000 2
100000 2 100000 2 10000 2 100000 2
1000 2 0 7 10000 2 10000
100 1 0 7 100000 2 1000 2
100000 1 0 7 100 2 100000 2
100000 1 0 7 100 2 10000 1
0 7 1000 2 1000 2 0 7
0 7 0 7 0 7 0 7
0 7 0 7 0 7 100000 1
100 2 0 7 100 1
100000 2 100000 2 100000 2 100000 2
0 7 1000 2 1000 2
1000 2 0 7 100000 2 100000 2
0 7 10000 1 100 2 0 7
1000 1 10000 1 100 1 100 1
0 7 1000 1 0 7 0 7
100 1 100000 1 100 1 100 1
0 7 10000 1 100 1 100 1
0 7 0 7 100000 2 0 7
100 2 0 7 0 7 10000 2
100 2 100000 1 100 2 100 2
0 7 1000 1 0 7 1000 2
100000 2 0 7 1000 2 100000 2
0 7 0 7 1000 1 100 1
0 7 100 2 0 7 1000 2
0 7 0 7 10000 2 10000 2
100000 1 0 7 10000 2 100000 2
0 7 0 7 0 7 100000 2
1000 2 100 2 0 7 100000 2
0 7 100000 1 10000 2 0 7
0 7 0 7 0 7 100 2
100000 1 0 7 10000 2 10000 2
10000 1 0 7 10000 1 100 1
100000 2 100000 2 100000 2 10000 2
0 7 0 7 100000 2 100 2
0 7 0 7 10000 2 100 2
0 7 0 7 0 7
0 7 100 2 0 7 10000 2
10000
GR‐cc‐ D7 Groin‐ D7
10000 2
0 7
100000 2
100000 1
0 7
100000 2
100000 2
1000 1
1000 1
0 7
100000 1
100000 2
100 1
100 1
0 7
1000 1
1000 1
0 7
100000 2
100000 2
100000 1
100000 1
1000 1
100000 1
0 7
100000 1
100000 2
10000 2
100000 2
100000 1
100000 2
0 7
100000 2
1000 2
1000 1
100 1
1000 2
0 7
100000 1
0 7
0 7
100000 2
100000 1
100000 1
100000 1
100000 2
0 7
0 7
0 7
0 7
100 2
1000 2
1000 2
100 1
0 7
0 7
1000 2
1000 2
100000 2
0 7
100000 2
10000 2
0 7
10000 1
0 7
0 7
0 7
0 7
100 1
1000 2
10000 1
100 1
1000 2
100000 2
100 2
100000 2
100000 2
1000 2
10000 2
10000 2
100000 1
0 7
0 7
0 7
0 7
100000 2
100000 2
100 2
1000 2
0 7
100 1
0 7
100 2
0 7
0 7
0 7
100000 2
0 7
0 7
0 7
100000 1
0 7
100 2
0 7
0 7
100000 1
100 1
10000 2
100 2
100 1
10000 1
